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“Die Kontroversen über die Cholelithiasis sind, trotz der über diesen Gegenstand 
vorliegenden, fast unübersehbaren Litteratur, noch weit davon entfernt, endgultig 
abgeschlossen zu sein. Denn wenn letzteres zwar in gewisser Beziehung von der 
Symptomatologie und von der Kenntnis der Genese der Steine gesagt werden darf, so 
sind immerhin innerhalb der Bakteriologie, der pathologischen Anatomie und der 
Behandlungsweise der Krankheit noch genug Punkte vorhanden, die einer auf 
fortgesetzte Beobachtungen gestützten Aufklärung harren.” 
 
~ ~ ~ ~ ~ 
 
“The controversies over cholelithiasis remain far from being definitively settled, despite 
the evident literature available on the subject. Whilst this may not apply, in some 
respects, to the symptomatology and the knowledge of gallstone genesis, there 
nonetheless continues to exist sufficient points within the bacteriology, the pathologic 
anatomy and the treatment of the condition that await clarification, warranted by 
continuous observations.” 
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”I will not cut for stone, even for patients in whom the disease is manifest; I will leave 
this operation to be performed by practitioners, specialists in this art.” 
 
The Hippocratic oath (460 BC – 377 BC) 
 ABSTRACT 
Background: Accidental injuries to the bile ducts are a rare but devastating 
complication to cholecystectomy, causing afflicted patients considerable morbidity, 
with subsequent impaired quality of life and significant health related costs. The 
knowledge regarding incidence, morbidity and prevention of such injuries is limited.  
Objectives: To investigate the incidence of bile duct injuries (BDI) in Sweden. To 
evaluate the long-term morbidity pattern after BDI. To estimate the mortality rate and 
factors associated with increased mortality following BDI. To address prevention of 
BDI by the identification of risk factors and evaluation of the possible protective effect 
by intraoperative cholangiography (IOC). 
Methods: In study I, all cholecystectomies within the Swedish Inpatient Registry 
between 1965 and 2005 were included. BDI were identified through International 
Classification of Diseases (ICD) procedure codes, pertaining to surgical reconstruction 
of the bile ducts, and analysed for survival, factors influencing the survival and causes 
of death. In study II and III, all cholecystectomies within the Swedish Registry for 
Gallstone Surgery, GallRiks, between 2005 and 2010, were analysed for BDI. Analyses 
regarding incidence, survival and risk factors for BDI were performed using 
multivariable Cox (Study II) and logistic regression (Study III) models. Study IV is a 
nested, matched case-control study of BDI patients (cases) and non-injured 
cholecystectomies (controls). After a review of medical records, multivariable logistic 
regression models were used to investigate the association between different severity-
grades of acute cholecystitis and BDI.   
Results: In study I, 374 042 cholecystectomised patients were identified, of which 
1 386 had reconstructed BDI. Survival was significantly lower in the injured group, 
with a hazard ratio of 3.73 at year one, which thereafter gradually evened out. The risk 
of dying from liver diseases was four-fold increased in the BDI cohort compared to the 
general population. In study II, 51041 cholecystectomies and 747 (1.46%) BDI were 
identified, ranging from minor to major injuries. Injured patients had an impaired 
survival compared to non-injured but early detection of BDI, during the primary 
operation, improved survival. The intention to use IOC reduced the risk of dying after 
cholecystectomy by 62% and reduced BDI rates by 29%. In study III, increased age, 
comorbidity and on-going or a history of acute cholecystitis were independent risk 
factors of BDI. Among patients with acute cholecystitis, the intention to use IOC 
reduced BDI risk by 66%. For patients with a history of acute cholecystitis, the 
equivalent reduction in risk was 41%. Among patients with uncomplicated gallstone 
disease, no preventive effect of IOC was seen. In study IV, 158 BDI and 623 controls 
were analysed. Mild acute cholecystitis did not increase the risk of BDI whereas 
moderate and severe forms gradually increased BDI risk. 
Conclusions: BDI is more common than previously reported, with reduced short and 
long term survival, partly due to an overrepresentation of liver related diseases. 
Increasing age, comorbidity and moderate to severe inflammatory changes of the 
gallbladder are important risk factors for BDI. The intentional use of IOC reduced BDI 
rates and improves survival after cholecystectomy. As the protective effect of IOC 
seems to be confined to patients with, or with a history of acute cholecystitis, routine 
IOC should be recommended within this group whereas a selective IOC approach 
among uncomplicated gallstone disease is likewise safe.  
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1 INTRODUCTION 
 
Cholecystectomy due to gallstones is one of the most common surgical procedures and 
is considered a routine operation in modern surgery. Although a routine procedure, the 
consequences of accidental injuries to the bile ducts may have a severe impact on 
health of afflicted patients, including mortality and considerable disability, and poses a 
major economic burden both to the individual patient and to the health care system at 
large[1-4].  
 
The knowledge about incidence, morbidity and prevention of iatrogenic bile duct injury 
(BDI) is limited. A majority of research is based on single centre experiences, usually 
presenting low morbidity and almost negligible mortality. These findings sharply 
contrast the results of the few larger population based studies reporting devastating 
morbidity and mortality figures almost resembling those of malignant disease[2].   
The relative paucity of BDI precludes research based on randomized controlled trials 
due to the massive sample sizes needed to obtain sufficient power. Epidemiological 
methods allow for studies of rare outcomes, but valid and conclusive research 
concerning risk factors and survival after BDI is scarce.     
 
This thesis, based on four original papers, aims at a better understanding of the 
incidence, consequences and prevention of BDI. Accurate estimations of BDI incidence 
is of fundamental importance for analyses of the impact on patients’ health, treatment 
outcome and costs. A thorough knowledge of morbidity and mortality after BDI is a 
prerequisite for optimal treatment and follow-up. By identifying risk factors and 
assessment of optimal surgical techniques, we can provide a scientific basis for 
effective primary prevention, thereby reducing the devastating consequences of 
iatrogenic BDI.  
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Figure 1. Anatomy of the biliary system. 
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2 BACKGROUND 
 
 
2.1 GALLSTONE DISEASE 
 
2.1.1 Historical perspective 
 
Gallstone disease, caused by genetic predisposition, dietary habits and environmental 
conditions has occurred throughout human history. The earliest known gallstone dates 
back to ancient Egypt, discovered in the mummy of a priestess of Amen (1085-945 
BC) and unfortunately destroyed during the bombing of London during World War II. 
The Greek physician Alexander Trallianus (525-605) was the first to describe 
“calculas” within the biliary ducts. With the revival of human dissection during the 15th 
and 16
th
 century, gallstones ant their clinical consequences were described. In 1586, 
Marcellus Donatus of Mantua , Italy, published a thesis on biliary tract pathology with 
descriptions of stones expulsed from the gastrointestinal tract through vomits and stool. 
In 1676 Joenisius removed gallstones from a spontaneous biliary fistula thereby 
describing the first cholecystolithotomy. 
The first steps of surgically addressing gallstones were taken by John S. Bobbs, 
Professor of Surgery at the Medical College of Indiana, USA. On June 15, 1867 he 
per-formed the first cholecystostomy in a patient operated for what he thought might 
be an ovarian cyst. He opened the gallbladder and removed around 50 gallstones. The 
patient had an uneventful recovery and a dramatic relief of pain. 
Carl Langenbuch was credited to have performed the first surgical removal of the 
gallbladder, a cholecystectomy[5], in 1882. Believing that stones can reform and thus 
the bladder had to be removed, he adopted the technique that essentially has been the 
treatment of choice to this day.   
During the following decades, steps were taken to improve diagnosis and treatment of 
gallstone related complications. The novel technique of radiology discovered by 
Wilhelm Conrad Röntgen (1845-1923) enabled radiological contrast-enhanced 
studies of the gallbladder. Cholangiography was first attempted via the gallbladder in 
1921 but due to frequent bile leakage not clinically feasible until the development of 
the transhepatic route, in 1952. Intraoperative cholangiography (IOC) during 
cholecystectomy, a radiologic contrast-based examination of the bile duct was first 
described in 1937 by Mirizzi, to help delineate the anatomy of the biliary tree in case 
of advanced biliary disease[6]. 
During the second part of the 20
th
 century, the cholecystectomy became a routine 
procedure performed in millions of patients all over the world. Even though methods 
for minimal invasive cholecystectomies were developed during the 1980s, such as 
mini-laparotomy, with a very small subcostal incision, few could predict the dramatic 
paradigm shift with the introduction of the laparoscopic cholecystectomy.  Prior to 
1990, the only field in medicine routinely using laparoscopy was gynaecology, 
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mostly for relatively short, simple procedures such as a diagnostic laparoscopy and 
tubal ligation.  
Erich Mühe[7] is recognised for the first laparoscopic cholecystectomy in 1985. In 
the beginning, the new technique was met with disbelief and scepticism by fellow 
German surgeons. His procedure was described as “Mickey Mouse surgery” while 
others remarked “small brain - small incision.” It was not until the French surgeons 
Mouret, Dubois and Perissat in 1987-1988, after the introduction of video techno-
logy, that information about the new procedure successfully was spread to the wider 
surgical community.  In 1989, Perissat presented his video of a laparoscopic 
cholecystectomy at the American Gastrointestinal Endoscopic Surgeons (SAGES) 
meeting in Louisville, KY, USA, and attracted great attention. A few months later 
Dubois's paper “Coelioscopic Cholecystectomy” was published in Annals of Surgery 
and found a large American audience[8]. Within a few years, the laparoscopic 
technique gained tremendous spreading but was initially restricted to uncomplicated 
gallstone disease. Acute cholecystitis and common bile duct stones were considered 
as contraindicated. Today, more than two decades later, laparoscopic 
cholecystectomy is used both in elective and emergent settings, addressing 
complicated gallstone disease making the open approach almost a rare event mainly 
used for particularly difficult cases.     
 
2.1.2 Gallstone formation 
 
Cholesterol stones are the most common group of gallstones (~90%) and form in the 
gallbladder[9]. They consists of cholesterol monohydrate and form due to 
supersaturated bile. Black stones (~2%) also form primarily in the gallbladder but are 
related to excessive levels of bilirubin in the bile. Brown pigment stones (~8%) form 
not only within the gallbladder but also within the intrahepatic and extrahepatic 
ducts[9]. They are infected with enteric bacteria or parasites and are usually associated 
with ascending cholangitis[9, 10]. Key mechanisms associated to the forming of 
gallstones are beside cholesterol or bilirubin supersaturation and infection also 
hypomotility of the gall-bladder[11] and disturbed enterohepatic circulation[12]. 
Genetic[13] (family history and ethnicity), environmental[14] (e.g. drugs and surgery) 
and lifestyle factors[15] (hyperchaloric diet, physical inactivity, obesity and rapid 
weight loss) have been identified as risk factors for gallstones.   
 
 
 
2.1.3 Gallstone epidemiology 
 
Gallstone disease prevalence is defined as patients with proved presence of gallstones 
and patients with evidence of cholecystectomy. The prevalence can be assessed by 
various techniques such as ultrasonography, cholecystography and autopsy surveys. 
The prevalence of gallstones in Europe and North America have been estimated to 10-
20%[16, 17] of the population and is related to female gender and advanced age. In 
Sweden, Muhrbeck et.al. (1995) using a population-based screening of men and women 
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aged between 40 and 60 years, found that the overall prevalence was 15%. Women had 
a prevalence of 11% at the age of 40 and 25% at the age of 60. The corresponding 
percentages among men were 4% and 15%[18]. Once one or more gallstones are 
present, they may grow, shrink, or remain essentially the same size for years. The 
incidence or rate of gallstone formation has been estimated using ultrasonography. 
Patients free of gallstones at baseline examination were re-evaluated within a 5-year 
period and the incidence of gallstones was estimated to be 1.39 per 100 person-
years[19].   
  
 
 
2.1.4 Natural history of gallstones 
 
Although evidently common, only a minority of patients with gallstones will become 
symptomatic. Most gallstones (60-80%)[20] do not generate symptoms and are 
incidentally found during radiology[21, 22]. Patients with asymptomatic gallstones are 
at a low risk of developing symptoms and studies have shown that approximately 1-2% 
of asymptomatic patients annually develop serious symptoms or complications[23]. 
However, a Swedish study concluded that nearly one out of ten patients with 
asymptomatic gallstones may be expected to develop symptoms or complications that 
require treatment within 5 years[24]. Why some stones remain silent without causing 
symptoms is still unclear and no differences in number, size or composition have 
been found comparing asymptomatic and symptomatic stones[25].  
 
 
 
2.1.5 Complications of gallstone disease 
 
2.1.5.1 Biliary colic 
 
Biliary colic is the classic manifestation of gallstone disease defined as pain in the 
epigastrium and/or hypochondrium lasting more than 30 minutes[26]. It is caused by an 
obstruction of the gallbladder by a gallstone, at the neck or in the cystic duct. This 
obstruction results in increased pressure in the gallbladder and subsequent pain. 
However, the symptomatology of gallstones is often difficult to distinguish from other 
disorders with similar patterns regarding pain and associated symptoms, most 
commonly dyspepsia[27]. Studies have shown that comparing gallstone disease with 
dyspepsia, abdominal pain was generally related to gallstones, whether unspecified or 
localized in the upper abdomen[28]. Pain radiating to the back or right shoulder was 
more strongly associated with gallstones than unspecified upper abdominal pain. The 
character of the pain is often steady or comes in attacks lasting for longer than 30 
minutes rather than pain in waves that suggests other conditions than gallstones[29]. 
Although a confirmed relationship between biliary colic and gallstones exists, the 
discriminative capacity is low. Biliary colic occurs in 20% of patients with gallstones 
and in 6% of patients without gallstones[30].    
 
Biliary colic has been shown to have an association with unspecified food 
intolerance[28], however no specific provoking food item has been identified. It is 
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somewhat noteworthy that fat intolerance, with probably the most commonly suggested 
relationship to symptomatic gallstone disease, never have been significantly associated 
in study settings[30].     
 
In conclusion, gallstone-associated symptoms are non-specific, and accurate diagnosis 
cannot rely on the clinical assessment alone. However, a careful clinical evaluation can 
guide patient selection for diagnostic imaging and facilitates the appropriate 
management of those found to harbour stones. 
 
 
2.1.5.2 Acute cholecystitis 
 
Acute cholecystitis is an acute inflammatory disease of the gallbladder. In 90-95% of 
cases, it is associated with gallstones[31-34], but many factors such as ischemia, 
infection by microorganisms, collagen disease and drugs may also contribute to acute 
cholecystitis. This inflammatory disease accounts for 3-10%[35, 36] of all patients with 
abdominal pain and develops in 1-3% of patients with symptomatic gall stones[23]. 
Most commonly, acute cholecystitis is caused by obstruction of the cystic duct by 
gallstones or by biliary sludge impacted at the neck of the gall bladder. If the 
obstruction is partial and of short duration, the patient experiences transient biliary 
colic. If the obstruction is complete and with long duration, the increased intraluminal 
pressure results in biliary stasis and triggers an acute inflammatory response[37]. 
 
The Tokyo Guidelines for the management of acute cholecystitis were developed in 
2007 and suggested a global definition as well as severity grading of acute 
cholecystitis[38] (Table 1). 
 
 
Table 1. Tokyo Guidelines diagnostic criteria for acute cholecystitis. 
 
 A. Local signs of inflammation: 
(1) Murphy’s sign, (2) Right upper quadrant mass/pain/tenderness 
B. Systemic signs of inflammation: 
(1) Fever, (2) elevated CRP, (3) elevated WBC count 
C. Imaging findings: 
Imaging findings characteristic of acute cholecystitis 
Suspected diagnosis: One item in A + one item in B 
Definite diagnosis: One item in A + one item in B + C 
Acute hepatitis, other acute abdominal diseases, and chronic cholecystitis should 
be excluded 
CRP C-reactive protein, WBC white blood cells 
 
 
For acute cholecystitis, abdominal ultrasonography and computed tomography (CT) are 
the imaging studies most commonly used. Sonograms typically show pericholecystic 
fluid (fluid around the gallbladder), distended gallbladder, oedematous gallbladder wall 
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and gallstones. Ultrasonography has a high sensitivity (90-95%)[39] in detecting acute 
inflammation of the gallbladder and should be considered for initial evaluation due to 
safety and cost-effectiveness[40].   
 
Acute cholecystitis is a very heterogeneous disease ranging from mild subclinical 
inflammation to necrotizing cholecystitis with perforation, biliary peritonitis and sepsis. 
In addition to diagnostic criteria, the Tokyo Guidelines group identified the need of a 
standardized severity grading system for the development of differentiated treatment 
algorithms and facilitation of comparable research findings[41] (Table 2).  
 
 
Table 2. Tokyo guidelines severity assessment criteria for acute cholecystitis.  
 ‘‘Grade III’’ (severe) acute cholecystitis is associated with dysfunction of any one of the following 
organs/systems 
1. Cardiovascular dysfunction Hypotension requiring treatment with dopamine >5 μg/kg per 
min, or any dose of norepinephrine 
 2. Neurological dysfunction Decreased level of consciousness 
3. Respiratory dysfunction PaO2/FiO2 ratio<300 
4. Renal dysfunction Oliguria, creatinine >2.0 mg/dl 
5. Hepatic dysfunction PT-INR>1.5 
6. Haematological dysfunction Platelet count<100,000/mm
3
 
‘‘Grade II’’ (moderate) acute cholecystitis is associated with any one of the following conditions 
1. Elevated WBC count (>18,000/mm
3
) 
2. Palpable tender mass in the right upper abdominal quadrant 
3. Duration of complaints>72 h 
4. Marked local inflammation (gangrenous cholecystitis, pericholecystic abscess, hepatic abscess, biliary 
peritonitis, emphysematous cholecystitis 
‘‘Grade I’’ (mild) acute cholecystitis does not meet the criteria of ‘‘Grade III’’ or ‘‘Grade II’’ 
acute cholecystitis. Grade I can also be defined as acute cholecystitis in a healthy patient with no 
organ dysfunction and mild inflammatory changes in the gallbladder, making cholecystectomy a 
safe and low-risk operative procedure 
WBC white blood cell 
  
Patients with severe acute cholecystitis may have mild jaundice caused by 
inflammation and oedema around the biliary tract causing a direct pressure on the 
biliary tract from the distended gall bladder. However, concentrations of bilirubin >60 
μmol/l suggest a diagnosis of common bile duct stone or Mirrizzi's syndrome 
(obstruction by a stone impacted in the neck of the gallbladder compressing the 
common hepatic duct). 
 
Early stage acute cholecystitis is generally considered to be non-bacterial but with 
increasing inflammation and ischemia of the gallbladder wall, overgrowth of enteric 
organisms and bacterial translocation may occur with subsequently increased morbidity 
and mortality[37, 42]. The role of antimicrobial therapy in early and non-severe cases 
of acute cholecystitis is unclear. In these patients, antimicrobial therapy is at best 
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prophylactic, preventing progression to infection. In other cases, with clinical findings 
of a systemic inflammatory response, antimicrobial therapy is therapeutic, and 
treatment may be required until the gallbladder is removed[43].  
 
2.1.5.3 Chronic cholecystitis 
 
Chronic cholecystitis is a disorder of the gallbladder with a thickened, shrunken bladder 
unable to properly concentrate, store, and release bile. The mucosa becomes atrophic 
and the normal bladder tissue is replaced by connective tissue in all wall layers. In long 
standing cases, the gallbladder wall may calcify, sometimes called a porcelain gall-
bladder. The mechanisms leading to chronic cholecystitis are not settled but it is usually 
believed to be caused by repeated attacks of acute cholecystitis. There is no relationship 
between the severity of inflammation and number of gallstones and findings suggest 
that chronic inflammatory changes can occur in the gallbladder mucosa prior to the 
appearance of macroscopic stones[44] Chronic acalculous cholecystitis, inflammation 
with absent stones, have been reported in as much as 5% of cholecystectomy 
specimens[45].  
Chronic cholecystitis is known to predispose for difficult surgery with increased 
conversion rates at laparoscopic cholecystectomy[46] and is considered to be a risk 
factor for gallbladder carcinogenesis[47, 48]. 
 
 
2.1.5.4 Common bile duct stones 
 
Common bile duct stones (CBDS) typically originate in the gallbladder and migrate. 
This is called secondary stones and should be differentiated from primary CBDS, a 
relative rare condition, with stones developing in the bile ducts mainly due to stasis and 
biliary infection.   
The prevalence of CBDS in patients with symptomatic gallstones is 10-20%[49-54]. 
The percentage of patients with CBDS detected at 2989 cholecystectomies in a 
Swedish study was 10.2%[55]. Another Swedish study of 647 cholecystectomies where 
88% had IOC, 8% of the patients were found to have CBDS, and the majority (53%) 
were discovered during IOC and thus not preoperatively detected[56]. 
 
Transabdominal ultrasound, excellent for the detection of gallbladder stones, is not as 
sensitive in the detection of CBDS. However, together with clinical suspicion it still is 
considered a first line modality due to its simplicity and safety, and can be used in 
selecting patients to more sensitive evaluations by computed tomography (CT) or 
magnetic resonance cholangiopancreatography (MRCP). Peroperative IOC is the 
optimal method for CBDS detection during cholecystectomy but is nevertheless 
controversial. Although safe and easy to perform, IOC adds time and costs to the 
procedure. It is furthermore evident that a fairly high percentage of CBDS will pass 
spontaneously. In a prospective study by Collins et. al., one third of cholecystectomised 
patients with suspected CBDS on peroperative IOC were found to have spontaneous 
ductal clearance within 6 weeks postoperatively[57]. On the other hand, it has been 
suggested that patients referred with post cholecystectomy complications due to 
residual CBDS are more frequent than generally considered[58] and the topic of how to 
optimally detect and handle peroperative CBDS remains unsettled. 
   9 
 
Although the natural history of CBDS is significantly less known than that of 
gallbladder stones, it is evident that when ductal stones become symptomatic the 
consequences are often serious and can include pain, partial or complete biliary 
obstruction, cholangitis, or pancreatitis. It is recommended that patients with 
symptomatic CBDS have the stones removed, but the methods are still controversial. 
Stones can be removed preoperatively, by endoscopic retrograde 
cholangiopancreatography (ERCP), intraoperatively by surgical or endoscopic means 
or postoperatively by ERCP.  
 
 
2.1.5.5 Biliary pancreatitis 
 
CBDS may be trapped in the common bile duct in the ampulla above the sphincter of 
Oddi and cause biliary pancreatitis. It is believed that 30%-60%[59] of acute 
pancreatitis cases are due to obstructing gallstones, with small, numerous stones and a 
large cystic duct being considered risk factors[60]. The majority of obstructing stones 
will be cleared spontaneously within 48 hours making early intervention with ERCP 
and sphincterotomy useless in terms of limiting the severity of the pancreatitis[61]. 
However, as the risk of recurrent episodes of acute pancreatitis is as high, patients with 
an episode of biliary pancreatitis should be considered for preventive 
cholecystectomy[62].       
 
 
2.1.5.6 Gallbladder cancer 
 
Gallbladder cancer is a rare malignancy with considerable geographical variations. It 
affects 1.2 per 100 000 persons in USA annually but varies considerable worldwide. In 
contrast, gallbladder cancer is considered a common form of cancer in Delhi, India, 
with 21.7 cases per 100 000 persons[63]. The prognosis is generally considered to be 
poor[64]. Gallstones have been stipulated as a risk factor for gallbladder cancer, with 
special emphasis to large stones and the time stones have been present in the 
bladder[65]. Recently, the causal relationship between gallstones and gallbladder 
cancer have been questioned and it is possible that the excretion of cholesterol from the 
liver, causing cholesterol stones, is joined by the hepatic excretion of other toxic 
compounds which in turn may be carcinogenic[66]. 
 
Patients with gallbladder wall calcification, i.e. porcelain gallbladder, have been 
associated with increased risk of developing gallbladder carcinoma. A systematic 
review of 124 calcified bladders showed a 6% rate of gallbladder cancer suggesting that 
prophylactic cholecystectomy for incidental radiological findings of this condition is 
suitable[67].     
 
Gallbladder polyps are considered to be a risk factor of gallbladder cancer with 
increasing rate of malignancy with increasing size of the polyp. However, the risk of 
malignancy resulting from incidentally detected small polyps is extremely low and 
watchful waiting can safely be recommended for polyps less than 10 mm[68]. 
Gallbladder cancer more commonly arises from dysplastic, rather than adenomous, 
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lesions, which suggests that identification of a thickened gallbladder wall should render 
more consideration than what is practice today[65].     
 
    
 
2.1.6 Treatment of gallstone disease 
 
2.1.6.1 Asymptomatic gallstones 
 
Asymptomatic gallstones, encountered incidentally without symptoms, have become an 
increasing problem as imaging procedures such as trans-abdominal ultrasound are 
readily available, safe and relatively inexpensive. It is particularly troublesome if 
functional disorders, with symptomatology resembling gallstone disease are incorrectly 
seen as a consequence of encountered stones. The crucial question is that if 
prophylactic cholecystectomy is justified regarding prevention of complications contra 
operative risk. In one study, a biliary complication was observed in less than 3% of 
asymptomatic gallstones after 10 year of follow-up[69]. Another study, following 
asymptomatic patients for 24 years, reported a 6% cholecystectomy frequency due to 
the development of symptoms[70].     
 
There have been no randomized controlled trials comparing cholecystectomy versus no 
cholecystectomy in patients with asymptomatic gallstones[71]. However, given the 
substantial knowledge regarding the commonness of gallstones, low risk of developing 
complications and cholecystectomy related morbidity, cholecystectomy cannot be 
recommended for patients having asymptomatic gallstones[72]. This recommendation 
includes patients with incidental findings of gallstones during surgery for other 
conditions[73]. 
 
 
2.1.6.2 Biliary colic 
     
Laparoscopic cholecystectomy is considered the preferred treatment for symptomatic 
gallstone disease, but the evidence for this could be questioned. Symptoms vary greatly 
and retrospective studies, following patients with symptomatic gallstones over several 
years suggest that cholecystectomy is not suitable for all patients and expectant 
management may also be a valid therapeutic approach[69, 74]. A Norwegian 
randomized controlled trial on patients with symptomatic, uncomplicated gallstone 
disease, compared outcome after surgery or observation. No important differences in 
outcome between the groups were seen at 5 or 14 years of follow-up[75, 76].  
In conclusion, surgery is still the preferred treatment among patients with intolerably 
frequent episodes of biliary colic but watchful waiting should likewise be an option 
considering mild symptoms, especially among elderly.  
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2.1.6.3 Acute cholecystitis 
 
The therapeutic standard for acute cholecystitis is cholecystectomy[32], even though 
the heterogeneity of this group necessitates alternative treatments.     
Between 10-15% of all cholecystectomies are performed due to acute cholecystitis[77]. 
Today, laparoscopic cholecystectomy is the preferred treatment as it involves shorter 
hospital stay and has similar frequency of morbidity and mortality as open 
cholecystectomy[78-81]. 
 
The appropriate timing of cholecystectomy in patients with acute cholecystitis has been 
debated and addressed in several randomized controlled trials[82-85]. The results 
suggest that conversion rates and overall complications following surgery within the 
first week of symptoms are similar to interval operation, after 6-8 weeks, but surgery 
within the first week leads to significantly shorter hospital stays[86, 87]. Furthermore, 
there is some evidence supporting immediate cholecystectomy, preferably with surgery 
as soon as possible following symptom onset (if at all possible within 72 hours of 
symptom onset)[88-90]. In the only large, registry based, study of 4113 patients with 
acute cholecystitis, complications associated to cholecystectomy timing were studied. 
Cholecystectomy at admission day had lower conversion rates, less complications, 
lower reoperation rates as well as shorter postoperative hospital stay compared to 
operation 6 days after admission[91].    
 
No randomized controlled trials have addressed the optimal surgical treatment for acute 
cholecystitis with regards to grade of severity. The Tokyo Guidelines proposed an 
algorithm recommending early laparoscopic cholecystectomy for mild forms (grade I), 
early laparoscopic or open cholecystectomy within 72 hours for moderate (grade II) and 
urgent management of organ dysfunction, control of local inflammation by drainage 
and/or cholecystectomy for severe forms (grade III)[92]. As cholecystectomy can be 
associated with substantial morbidity and mortality within subgroups of patients[93, 
94], cholecystostomy, percutaneous drainage of the gallbladder, may be an alternative 
treatment for high risk patients but this should be further evaluated in a randomized 
study setting[95]. 
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2.2 IATROGENIC BILE DUCT INJURY 
 
Iatrogenic BDI during cholecystectomy is one of the most dreaded complication among 
surgeons performing cholecystectomy. This thesis addresses important questions 
concerning occurrence, consequences and prevention of such injuries.   
 
 
2.2.1 Classification of bile duct injury 
 
The management and outcome of BDI vary considerably and are highly dependent on 
injury localization, extent of the lesion and possible associated injuries such as vascular 
or bowel injuries. An optimal classification system has to be detailed enough to 
differentiate between injuries with different clinical and therapeutic entities, but simple 
enough to be adopted and used. Regarding BDI, no single classification system has 
been globally accepted as standard, making the comparison of research findings 
troublesome and precluding efficient metanalyses.  
 
 
2.2.1.1 Bismuth’s classification 
Traditionally, BDI have been 
classified according to 
Bismuth’s classification[96], 
originating from the era of open 
surgery and intended to help 
surgeons to choose the most 
suitable repair technique for 
postoperative biliary strictures. It 
describes the most distal level at 
which healthy biliary mucosa is 
available for anastomosis. The 
introduction of laparoscopic 
cholecystectomy led to new and 
more severe injuries, not 
possible to classify using 
Bismuth’s system[97]. However, 
it still remains as an important 
baseline for newer and more 
differentiated classification 
systems.  
 
 
 
 
 
 
Figure 2. Bismuth classification of BDI. 
 
  
Type II 
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Type III Type IV 
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2.2.1.2 Strasberg’s classification 
 
The Strasberg 
classification[97] (Figure 3) 
was introduced in 1995, when 
the laparoscopic technique 
was well established. It 
extended Bismuths’ 
classification to a more 
comprehensive categorisation, 
with the ability to describe 
and differentiate more types 
of extrahepatic injuries. 
Strasberg’s classification is 
the most commonly used 
among clinicians, stratifying 
injuries from type A to E, with 
E-injuries further subdivided 
according to Bismuth’s 
classification. One limitation 
with Strasberg’s classification 
is that it does not include 
concomitant vascular injuries, 
which is highly relevant due 
to the added complexity and 
morbidity associated with 
such lesions[98]. 
 
 
 
 
 
 
 
 
Figure 3. Strasberg classification of BDI. 
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2.2.1.3 Hannover classification 
 
The Hannover classification[99] of BDI was introduced in 2007, offering a strong 
association between injury discrimination and treatment and including vascular injury 
(Figure 4).  Although probably too complex to become commonly used in the daily 
clinical setting, it offers advantages in research, and the detailed injury description is 
fully transferable to the majority of other existing classification systems. Concomitant 
vascular injury is denoted with a suffix; right hep. artery (d), left hep. artery (s), proper 
hep. artery (p) common hep. artery (com), cystic artery (c), portal vein (pv) (e.g. D3d).  
    
 Type A  
 Peripheral bile leak (with reconnection to the 
 main bile duct system) 
A2             A1 Cystic duct leak 
A1                       A2 Leak in the region of the gallbladder bed 
  
  Type B 
  Stenosis of the main bile duct without injury 
  (i.e. caused by a clip) 
B1  B1 Incomplete 
      B2 Complete 
     
B2  Type C 
       Tangential injury of the common bile duct 
  C1 Small punctiform lesion (< 5 mm) 
  C2 Extensive lesion (> 5 mm) below the hepatic  
C4   bifurcation 
C3  C3 Extensive lesion at the level of the hepatic  
C1   bifurcation 
  C4  Extensive lesion above the hepatic bifurcation 
C2 
  Type D 
  Completely transected bile duct 
  D1  Without defect below the hepatic bifurcation 
D4  D2 With defect below the hepatic bifurcation 
D3  D3 At hepatic bifurcation level (with or without  
   defect) 
D2  D4 Above the hepatic bifurcation (with or without 
D1   defect) 
   
  Type E 
E4  Strictures of the main bile duct 
E3  E1 Main bile duct short circular (< 5 mm) 
  E2  Main bile duct longitudinal (> 5 mm) 
E2  E3 Hepatic bifurcation 
E1  E4 Right main bile duct/segmental bile duct  
 
Figure 4. Hannover classification of BDI. 
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2.2.1.4 Other classification systems 
 
As a complement to the original Bismuth’s classification, other types of classification 
systems for BDI have been proposed and are used to various extents. McMahon et. 
al.[100] suggested a division into major BDI (laceration > 25% of the bile duct 
diameter, transection of the common bile duct (CBD) or common hepatic duct (CHD) 
or post-operative bile-duct strictures) or minor BDI (laceration of CBD < 25% of 
diameter or laceration of cystic-CBD junction). The Amsterdam classification[101] 
subdivides into four groups with relation to suggested treatment options. Stewart-
Way’s[102] and Csendes’[103] classifications addresses the injury mechanism, 
whereas the Neuhaus’[104], Siewert[105] and Chinese University of Hong Kong[106] 
describes possible lesions in slightly different ways. 
 
 
2.2.2 Incidence of bile duct injury 
 
Numerous authors have reported incidence figures of BDI before and after the 
introduction of the laparoscopic technique. During the open era the incidence of BDI 
was reported on an average of 0.25% (ranging from 0% to 0.90%)[107-113] and 
increased to 0.55% (ranging from 0.15% to 0.74%)[114-122] after the introduction of 
laparoscopy. The increased incidence of BDI observed during the 1990s can to some 
extent be explained by the learning curve of the laparoscopic technique[120], but it 
seems like the incidence figures remains moderately elevated throughout the 
laparoscopic period.  
 
Some concerns can be raised regarding the comparability of these BDI-incidence 
reports. In the period of open cholecystectomy, BDI incidence figures constitutes 
mainly of single centre (or a few multi-centre) case series or questionnaire surveys with 
self-reported data and possible doubts regarding BDI identification and definition. 
After the introduction of laparoscopy, larger population based studies were conducted 
with more objective complication identification although to the majority only 
measuring major BDI requiring surgical repair. “True” incidence figures of the whole 
range of BDI can probably only be achieved by large prospectively collected quality 
registries, with sufficient coverage and objective registration of peroperative and 
postoperative complications. Although national registries of gallstone-related 
interventions now exist, no data of sufficient quality have yet been reported. 
 
 
 
2.2.3 Consequences of bile duct injury 
 
2.2.3.1 Morbidity and mortality 
 
A BDI is associated with substantial morbidity. The expected short hospital stay or 
planned day-care surgery of an uncomplicated cholecystectomy is in sharp contrast to   
the often complicated, prolonged and uncertain recovery after a BDI.  
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The majority of BDI are not detected during the initial cholecystectomy[115, 123, 124] 
and the diagnosis is preceded by symptoms and complications due to bile leakage or 
stricture formation. Undiagnosed or improperly handled post-operative bile leakages 
have high risk of subsequent generalized peritonitis. Biliary peritonitis has been shown 
to be an independent risk factor for death in comparison to other causes of secondary 
peritonitis, emphasizing the need of early diagnose and intervention in this group of 
patients[125]. Percutaneous, endoscopic or surgical interventions and re-interventions 
add complexity and further risks, making the patients often committed to a decade of 
post-operative follow-up[123].  
 
In 2003, a nationwide population-based study of 1 562 450 cholecystectomies with 
7911 surgically reconstructed BDI within the Medicare social insurance program in 
USA, Flum et. al.[2] reported devastating outcome after reconstructed BDI. Only 
19.2% of BDI patients survived to the last common follow 9.2 years after the operation 
compared to 55.2% in the non-injured group. The adjusted hazard ratio (HR) for death 
among BDI-patients was 2.8 times higher than that of non-injured patients. These 
finding were in sharp contrast to the relative good long-term results previously reported 
from the open and laparoscopic periods, which showed mortality rates ranging from 0-
14.2% based on a total of 602 BDI patients during an average follow-up period of 41.3 
months[103, 126-139]. In 2007, DeReuver et. al.[140] published a single centre study 
of 500 BDI patients in a Dutch national referral hospital during 1990-2005. They 
reported excellent long term result and mortality rates not significantly different from 
the general population. In comparison, the results from Flum’s study are potentially 
seriously confounded, as the study population from Medicare beneficiaries consisted 
mainly of elderly and persons with substantial healthcare needs and precarious 
economic situations, and only injured patients requiring surgical reconstruction were 
defined as BDI. Their results should thus be interpreted with care and are hardly 
representative to the general population. On the other hand, the contrasting figures of 
DeReuver et. al. could to some extent be explained by a selection of merely referred 
BDI, excluding patients that had already died due to complications prior to referral. 
However, the result undoubtedly reflects the importance of a multidisciplinary 
approach to BDI at an expertise hepatobiliary centre.  
 
The morbidity and mortality risks associated with BDI are serious, but to fully 
comprehend the impact on afflicted patients, further studies with more carefully 
adopted selection criteria, are needed.    
 
                  
2.2.3.2 Quality of life 
 
In one of the first studies addressing quality of life, Boerma et.al.[4] assessed the 
impact of BDI on physical and mental quality of life (QOL) using the standardized 
questionnaire SF-36. Despite excellent functional outcome after repair, 106 patients 
sustaining BDI reported reduced QOL compared to non-injured controls. De Reuver et. 
al.[141] reported a longitudinal QOL study of 403 patients that suffered BDI. They 
compared QOL after, on average 5.5 and 11 years following the BDI. Their results 
suggested that QOL was impaired compared to non-injured and no improvement during 
the follow-up period was observed. Further studies have confirmed these findings[142], 
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mainly regarding psychological factors, associating a worse outcome with prolonged 
treatment period and legal procedures. Patients suffering BDI are often disappointed 
and feel neglected by many surgeons’ reluctance to admit their own mistakes, 
emphasizing the need of an honest doctor-patient communication and thorough 
information following BDI events. 
 
       
2.2.3.3 Economic aspects 
 
Surgery with complications goes with a need of substantial resources. An operation that 
leads to BDI adds not only hospital days, diagnostic radiology, expensive endoscopic or 
surgical interventions but also the costs of prolonged sick-leave and loss of production. 
A few studies have been conducted to estimate the economic impact of BDI. Andersson 
et. al.[143] calculated the annual costs per 1 000 000 inhabitants in Sweden by 
analysing actual in-hospital costs and loss of production of minor and major BDI. The 
average cost per patient was €21 837 for minor BDI and €107 568 for major BDI. After 
adjusting the figures by BDI incidence, the costs were estimated to be within the range 
of €136 787-€159 585 for minor BDI and €473 690-€608 789 for major BDI per 
million inhabitants. 
 
In an American study, Savader et. al.[144] showed that for 49 BDI patients at the Johns 
Hopkins Hospital, Baltimore, Maryland, the average in-hospital costs associated with 
the complete treatment of the patients was $51 411 (€66 976), excluding the costs for 
sick-leave and loss of production. 
 
From the medico-legal point of view, financial compensation is a measurement of the 
estimated economic burden associated with BDI. Statistically, surgeons are more at risk 
of litigation following laparoscopic cholecystectomy than they are after any other 
general surgical procedure, although with great differences between countries. In the 
UK, Roy et.al.[145] evaluated 83 claims following BDI during laparoscopic 
cholecystectomy between the years 2000 and 2005. An average of €64 681 were 
rewarded the patients and delayed recognition of the injury was correlated to increased 
risk of litigation. In comparison, the average payment per BDI claim was €12 795 in 
the Netherlands[146] and €650 000 in United States[147].         
 
 
 
2.2.4 Prevention of bile duct injury 
 
By far the best way to treat BDI is by prevention. But is this possible? Should a BDI be 
regarded as an unfortunate complication or is it a preventable error? In a Canadian 
survey, the majority of questioned surgeons felt that BDI could not be anticipated and 
as such is an inherent risk of the procedure[148]. On the other hand, many surgeons 
have reported large series of laparoscopic cholecystectomies without a single 
BDI[149]. To properly address this question, it is essential to understand the underlying 
mechanism of how BDI occur, most commonly by a misidentification or 
misinterpretation of biliary anatomy. Way et. al.[150] analysed 252 laparoscopic 
cholecystectomies with major bile duct injuries and came to the conclusion that in the 
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vast majority of BDI, the CBD or CHD were misidentified for the cystic duct or the 
surgeon dissected too close to the CHD. It was not faulty decision-making, lack of 
knowledge or plain clumsiness that caused the injury. Way et. al. concludes that when 
surgeons inspect the gallbladder, the subconscious brain seeks a recognizable pattern to 
match the mental model of the biliary tree. The brain makes a subconscious 
identification of the cystic duct (an illusive decision in the case of a BDI) and it is 
extremely difficult to change this perception. In laparoscopy, the perception is mainly 
visual in contrast to open surgery, in which haptic feedback can guide the surgeon to a 
correct interpretation of underlying structures. This difference in perception may to 
some extent explain the increased BDI incidence with laparoscopic approach. 
 
To prevent BDI we thus have to find strategies aiding surgeons to make correct 
interpretations of the biliary anatomy; Risk factor identification makes the surgeon 
aware of patients or situations where the risk of misinterpretation is increased. 
Development of surgical techniques that emphasizes on making the few risky parts of a 
cholecystectomy more standardized and safe as well as the proper use of technology, 
e.g. IOC used in order to verify the anatomy.   
 
 
2.2.4.1 Risk factors for bile duct injury 
 
2.2.4.1.1 Advanced age 
Advanced age has been proposed as a risk factor for BDI[118, 120, 122]. Physiologic 
tissue changes with ageing may be a possible explanation to some of the increased risk. 
However, even though these studies controlled for confounding factors, it is likely that 
they suffer from residual confounding. Older persons more commonly have higher 
comorbidity, and are thus more likely to have had complications such as acute and 
chronic inflammation and more frequently have adhesions obscuring the surgical field.  
 
2.2.4.1.2 Gender 
Male gender has been associated with difficult surgery during many abdominal 
procedures[151]. Although Grönroos et.al. showed evidence of the opposite[152], the 
few population based studies with sufficient power associates male gender to increased 
risk of BDI[118, 122, 153], although with questionable confounder adjustment. 
However, the mechanism of such association is not fully understood. It is possible that 
the male abdomen is more difficult when it comes to laparoscopic surgery, as 
significant higher conversion rates have been reported among men[154]. Furthermore, 
male gender has been associated with a higher rate of acute cholecystitis or sequele 
from previous acute cholecystitis[155] which increases the surgical difficulties. 
Another explanation might be that the proportion and distribution of obscuring intra-
abdominal fat differs between genders. 
 
2.2.4.1.3 Inflammation 
As acute cholecystitis is associated with increased conversion rates and overall 
complications compared to uncomplicated gallstone disease, it has been almost 
generally accepted as a risk factor for BDI. However, the evidence for an association 
between acute cholecystitis and BDI is weak. Considering larger population-based 
studies addressing risk factors for BDI, no difference in BDI rates was observed 
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between patients with and without inflammation[118, 120, 156]. However, 
methodological limitations makes the results less powerful. Giger et. al.[153] suggested 
that acute cholecystitis should not be regarded as a risk factor when comparing to a 
heterogeneous control group consisting of patients with symptomatic gallstone disease 
or chronic cholecystitis. The only studies with reported significant increased BDI rates 
associated with acute cholecystitis are relative small case series[157, 158] from single 
institutions with the most dramatic impact of acute cholecystitis seen during the first 
years of the laparoscopic technique[158]. 
 
There are a number of issues related to the identification of associations between 
inflammatory changes of the gallbladder and BDI. The presence of acute cholecystitis 
in population based research is mainly based upon ICD-diagnosis codes, which have 
been proven unpredictable in many research settings[159]. In studies with acute or 
chronic cholecystitis defined by the surgeon’s evaluation of the gallbladder during 
operation, the results are at high risk of being biased by the likely possibility of more 
severe descriptions by surgeons causing BDI. The possible relationship between 
inflammatory changes of the gallbladder and BDI has not yet been validly shown, and 
remains an important question as acute cholecystitis is a common and important 
indication for cholecystectomy. 
 
2.2.4.1.4 Surgeon related risk factors for bile duct injury 
The experience and characteristics of surgeons causing BDI have been addressed by 
many researchers. During the period of open cholecystectomy Andrén-Sandberg[160] 
noticed that the majority of surgeons causing the BDI were doing their residency. In 
1995, Moore et. al.[161] reported that 90% of BDI occurred within the first 30 
operations performed by an individual surgeon. Similarly, Gigot et. al.[138]  reported a 
twofold incidence of BDI among surgeons with less than 50 cholecystectomies 
compared to surgeons with experience of more than 50 operations. In their analysis of 
Medicare beneficiaries, Flum et. al.[162] showed that BDI occurred mainly during a 
surgeons first 20 cholecystectomies. In addition, a survival analysis on the same cohort 
of patients showed slightly decreased mortality after BDI if the surgeon performing the 
cholecystectomy was a surgical specialist[2]. Furthermore, teaching hospitals have 
been related to a twofold increased risk of BDI in one study[118] whereas no difference 
was seen in another[163]. However, a proper and dedicated laparoscopic training 
program has the potential of reducing this increased BDI incidence among 
inexperienced surgeons[164].  
 
The association between BDI and inexperience was most noticeable in the early years 
of the laparoscopic technique and has diminished since laparoscopic cholecystectomy 
became standard of care. It is furthermore obvious that experience is not a guarantee 
against BDI, as many injuries are caused by surgeons with more than 100 laparoscopic 
cholecystectomies[138].       
 
2.2.4.1.5 Anatomical variations 
Biliary tree anomalies have been reported to occur in 19-25% of patients[165, 166], and 
constitutes a risk factor for BDI. Most commonly, a right hepatic segmental or sub-
segmental duct drains separately into the CHD between the hepatic confluence and the 
cystic duct or directly into the cystic duct. These anomalies increase the possibility of 
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misidentifying the aberrant duct as the cystic duct. If IOC is performed through an 
aberrant right segment or sub-segment duct, very few surgeons would recognize the 
“missing” segmental duct on the cholangiogram. It is thus the use of safe surgical 
technique that is most important in the prevention of BDI in cases of anatomical 
variations.  
 
2.2.4.2 Safe surgical technique 
 
As the main cause of BDI is due to misidentification of the CBD/CHD being the cystic 
duct, the goal of dissection is a conclusive identification of the cystic duct. A few 
strategies have been proposed for this: (1) Dissection of the main bile ducts so that the 
uniting point of the CBD and cystic duct is identified; (2) The infundibular technique. 
(3); The critical view of safety technique and (4) Intraoperative cholangiography. 
 
(1) Laparoscopic dissection of the main bile ducts in order to identify the junction 
of the CBD and the cystic duct has been a method for reliable identification of 
the cystic duct prior to division. However, this method should not be 
encouraged as it is potentially very dangerous and the risk of damage to the 
CHD/CBD during dissection is increased. 
 
(2) In the infundibular technique, the cystic duct is isolated and followed into the 
gallbladder by dissecting the front and back of the triangle of Calot. When the 
cystic duct gradually becomes the gallbladder infundibulum, it is taken as 
evidence of identification and the structure may be divided. Although the 
infundibular technique have been commonly used and taught, it has 
disadvantages. The cystic duct may be hidden, especially in cases of 
inflammation and suboptimal lateral traction of Hartmann’s pouch. This may 
lead to a false infundibulum with subsequent misinterpretation of the CBD as 
the cystic duct[167].   
 
(3) The critical view of safety technique, described by Strasberg in 1995[97] deals 
with the potential problems of the infundibular technique. The method requires 
complete dissection of the triangle of Calot and separation of the base of the 
gallbladder from the liver bed prior to division of the suspected cystic duct. 
After proper dissection, only two structures enter the gallbladder, the cystic duct 
and the cystic artery, which can be divided safely. The critical view of safety 
should be considered as golden standard technique of laparoscopic 
cholecystectomy with a likely reduction of misidentification injuries if properly 
used.   
 
(4) With the introduction of laparoscopic cholecystectomy and the subsequent 
increase in BDI, IOC, formerly used mainly for CBDS detection, was 
introduced as a “road-map” in order to avoid major BDI. Today, more than two 
decades since the laparoscopic procedure was introduced, the use of IOC to 
prevent BDI is probably one of the most debated and controversial topics in this 
field of surgery. It thus deserves a thorough analysis.  
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2.2.4.3 Intraoperative cholangiography 
 
A search of intraoperative cholangiography and cholecystectomy in the online 
bibliographic database PubMed renders 1420 results, of which 260 have been published 
during the last 20 years. Despite the immense research on this topic, the level of 
scientific evidence is generally poor and the key questions of whether IOC prevents 
BDI and if it should be routinely or selectively used, are being far from settled.  
 
Surgeons who do not use IOC, claims it to be unnecessary, costly and time consuming 
and that BDI can be avoided without using IOC. Selective users believe they can 
identify the subgroup of patients at high risk of BDI and apply IOC selectively on them. 
Furthermore, selective IOC users consider the patient’s benefit, from the detection of 
unexpected common bile duct stones by IOC, to be limited not justifying the added 
costs. Routine users argue that it is not possible to identify patients with no risk of BDI 
and thus routine use is safer.    
   
The main problem in studies of a hypothesized causal association between IOC and 
reduced BDI rates is due to the relative uncommonness of BDI. Given an expected 
reduction in BDI rate from 0.4% to 0.2% with the use of IOC, such a trial would 
require a sample size of more than 10 000 patients to detect a difference with 80% 
power. Nevertheless, at least four randomized controlled trials (RCT) of IOC vs. no 
IOC and one of routine vs. selective IOC have been conducted[168-173].  The mean 
sample size of these studies was 233 (115-303), a total of 4 BDI was observed and the 
results were inconclusive (Table 3). Unfortunately, the heterogeneity of these studies 
precludes further meta-analyses[174].  
 
 
Table 3. Randomized controlled trials of IOC and the risk of BDI. 
 
   No. of 
patients 
BDI 
 
Author Year Included patients IOC No IOC 
p-
value 
Khan et. al. 2011 Low risk of CBDS, LC 190 0 1 NS 
Nies et. al. 1997 Low risk of CBDS, LC, OC 275 0 1 NS 
Soper et. al. 1994 Low risk of CBDS, LC 115 0 0 NS 
Hauer-Jensen et. al. 1986,1993 Low risk of CBDS, OC 280 0 0 NS 
       
    
Selective 
IOC 
Routine 
IOC  
     Amott et. al. 2005 Non-selective, LC 303 1 1 NS 
 
LC: Laparoscopic cholecystectomy, OC: Open Cholecystectomy, NS: Non significant 
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Addressing the same question of an IOC-BDI association, and suffering identical 
sample-size issues, many researchers have reported their experiences with case series at 
single centres[175-179]. Due to the sample-size problem, none of these series offers 
valid evidence on the association between IOC and BDI.  
 
In an effort to handle the problem of small sample-sizes, Ludwig et. al.[180] performed 
a meta-analysis of 26 different single-centre case series, identifying 405 major injuries 
and performed a sub-group analysis on 103 BDI patients and the relationship to IOC. 
With routine IOC usage, 90% of injuries could be diagnosed intraoperative, compared 
to a 45% intraoperative detection rate in the selective IOC group. Furthermore, small 
incomplete incisional injuries to the CBD were the most common injury in the routine 
group whereas larger dissection injuries > 5 mm were most common in the selective 
group. The results speak in favour of routine IOC use and hypothesis a down-staging 
effect of IOC on BDI severity. However, major methodological questions regarding 
selection, heterogeneity and possible confounders makes these general conclusions 
questionable. 
 
Nuzzo et. al.[181] collected questionnaire-based information of 56 591 
cholecystectomies from 184 Italian hospitals, and they found no significant benefit 
comparing routine vs. selective use of IOC. However, the categorization and definition 
of routine or selective use is questionable, and self-reported data, especially concerning 
surgical errors, should be interpreted with care. 
 
Population-based studies on administrative data have the advantage of large sample 
sizes, which makes it possible to test for associations between outcome (BDI) and 
exposure (IOC). Possible confounder adjustment, inherently addressed by 
randomization in an RCT, can be dealt with using logistic regression modelling. Larger 
population based studies, reporting on the IOC-BDI relationship, are listed in table 4. 
  
In the first large population based study by Fletcher et.al.[118], 20 084 
cholecystectomies in Western Australia were searched for complications including 
BDI. A reduction of intraoperative complications, “bile duct injuries, other injuries and 
major bile leaks”, were seen with the use of IOC (Odds ratio (OR) 0.5 95% CI 0.35-
0.70). In 2006, Hobbs et. al.[182] using the same data together with cholecystectomies 
from the subsequent four years, and a total of 33 309 operations, reported reduced 
complication rates with an OR of 0.72 (95% CI 0.55-0.93). In two studies, using 30 630 
and 1 570 361 cholecystectomies respectively, Flum et. al.[162, 183] analysed 
reconstructed BDI and noticed a multiadjusted significant OR for BDI of 0.63 and 0.58, 
respectively, when IOC was used compared to when it was not used. Using identical 
methodology, Waage et. al.[122] analysed 152 776 cholecystectomies in the Swedish 
Inpatient Registry between 1987 and 2001, and noticed an adjusted OR of 0.75 (95% 
CI 0.59-0.92) for reconstructed BDI when IOC was used.  
 
In contrast to these findings Z’Graggen et.al.[184] in 1998 and Giger et.al.[153] in 
2011 used the Swiss Association of Laparoscopic and Thoracoscopic Surgery, 
(SALTS), registry to evaluate complications during cholecystectomy. No significant 
effect of IOC was seen on, somewhat poorly defined, BDI.  
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Questionable causality is a main issue with IOC-BDI research. It is likely, that some of 
the protective effect with IOC is not due to the procedure per se. Surgeons performing 
IOC on a routine basis may perform safer surgery during the whole procedure and IOC 
thus merely becoming a proxy for careful surgeons, less likely to cause careless 
injuries.  
Flum et. al addressed this problem in their Medicare study[162]. Comparing routine 
versus selective IOC users regarding the incidence of BDI, routine surgeons had the 
lowest BDI rates, but only when they used IOC. When IOC was not used among 
routine users, the surgeons were at similar or even increased risk of injury as selective 
IOC users. However, the authors did not address the problem of unsuccessful IOC 
attempts, which is one of the major problems with administrative data that could 
potentially bias their result. The success rate of IOC varies, ranging from 66% to 98.9% 
in the before mentioned RCTs. As usually only successful IOC is registered with ICD-
procedure codes, unsuccessful attempts due to generally difficult circumstances will be 
recorded as no IOC. A selection of difficult BDI-prone cholecystectomies will thus fall 
into the no IOC group, possibly explaining the increased BDI rate when routine users 
“chose” not to perform IOC.  
Furthermore, some selective IOC users may only intervene with an IOC when a BDI 
has occurred, for injury confirmation prior to repair. This would cause a higher BDI 
rate in the IOC group, falsely diluting a possible protective effect. 
 
These uncertainties, regarding the surgeons’ different reasons for performing IOC are 
usually the main valid arguments against the protective effect reported in the majority 
of population-based studies.   
 
It is evident that the IOC procedure in some cases may cause injuries[185], especially 
in the presence of inflamed, fibrotic, or short cystic ducts. Furthermore, IOC may be 
incorrectly interpreted and falsely convincing the surgeon of a normal anatomy[150]. 
To address this problem, some centres have adopted a routine of having radiologists 
interpreting the cholangiograms by telecommunication, allowing for real-time 
evaluation by dedicated experts.   
 
Additionally, the main indication for IOC usage in the pre-laparoscopic era, detection 
of CBDS is still valid and should be kept in mind. In a Swedish study[56], 8% of 
patients with IOC during cholecystectomy were found to have CBDS, the majority 
being detected intraoperatively and thus not suspected preoperatively. Even though the 
clinical relevance of asymptomatic CBDS is unclear, this argument should be added to 
a possible protective effect against BDI whilst evaluating the pros and cons of IOC.  
 
 
2.2.4.3.1 Intraoperative cholangiography and cost-benefit 
The cost of an IOC varies depending on reimbursement system and the way it is 
calculated, ranging from $700[170, 177]  to $100[186, 187]. In a cost-benefit analyses 
of IOC, Flum et. al.[188] calculated the difference in average costs of laparoscopic 
cholecystectomy with IOC ($8 649) to the average cost of laparoscopic 
cholecystectomy without IOC ($8 527) and concluded that IOC adds an average cost of 
$122 for IOC. Given the incidence numbers and mortality rates of BDI, the cost per 
life-year saved would be $13 900. Generally, interventions providing patients with one 
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life-year for less than $50 000, e.g. dialysis and seat-belts, are considered to be cost 
effective[189]. 
 
2.2.4.3.2 Alternatives to intraoperative cholangiography  
A few alternatives to IOC have been suggested. The performance of a 
cystocholangiogram, through a catheter placed in the gallbladder has been shown to 
accurately delineate the bile tree and has been proposed as a safer alternative to 
IOC[190] .However, occlusive stones in the gallbladder pouch or cystic duct, not 
uncommon in acute cholecystitis, substantially limit the usefulness.  
Laparoscopic ultrasonography has the advantage of noninvasively being able to 
demonstrate the biliary anatomy and possible CBDS at least as good as IOC[191-193] . 
However, the technique is very user dependent with need of ultrasonography skills. It is 
furthermore not readily available and is unlikely to become part of the toolbox of a 
general surgeon.   
 
In conclusion, although substantial research efforts have been undertaken in order to 
evaluate a possible protective effect of IOC, the level of evidence is fairly poor. During 
recent years, quality registries with prospectively collected an validated data have the 
potential of addressing rare outcomes such as BDI with much more reliable estimates 
of incidence and effect of preventive actions such as IOC.   
 
 
 
2.2.5 Diagnosis and treatment of bile duct injury 
 
A BDI is discovered during the primary cholecystectomy (approximately 30%[194]), 
early after surgery or late, weeks to months after injury. A variety of treatment options 
are available ranging from simple draining to highly advanced reconstructive biliary 
and vascular surgery. It is important to do things right from start, and the early 
involvement of hepatobiliary expertise cannot be emphasized enough.     
 
 
2.2.5.1 Peroperatively detected bile duct injury 
 
If not discovered during IOC, a peroperatively suspected BDI should be confirmed with 
IOC if this can be performed safely[195]. Conversion and a subsequent primary repair 
should be performed by surgeons with experience in biliary reconstructive surgery, and 
further dissection, for confirmation of injury extent, should never be performed.  
 
If no hepatobiliar expertise is available, it is preferable to not convert, insert a sub-
hepatic drain laparoscopically and then refer the patient to a hepatobiliary unit for 
delayed repair. Primary repair by the same surgeon who caused the injury has been 
associated with poor outcome. Stewart and Way[195] reported only 17% successful 
repairs and Flum et. al.[2] reported an 11% increased mortality rate associated with 
repair attempted by the injuring surgeon.       
The optimal strategy for an early repair still remains controversial. Small incisional 
injuries to the CBD or CHD are commonly repaired with direct closure and a T-tube. It 
may be successful but have also been reported to form strictures in almost every second 
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case[195]. Completely transected ducts require more extensive reconstructive surgery. 
End-to-end repair have been reported to be unsuccessful in the vast majority of 
cases[195], even though the early reported devastating results may be somewhat 
exaggerated[196]. The preferred reconstructive method is without doubts Roux-en-y 
hepaticojejunostomy, especially if the injury involves loss of ductal tissue or associated 
thermal or vascular injury. It is of great importance to delineate the extent of the injury 
and perform the anastomosis on vital, well vascularized ductal tissue, minimizing the 
risk of stricture formation within the anastomosis.          
 
 
2.2.5.2 Postoperatively detected bile duct injury 
 
Patients with postoperative symptoms as persisting pain, fever, nausea, jaundice or 
elevated laboratory findings (CRP, WBC and liver samples) should be evaluated with 
ultrasonography or abdominal CT, bearing a possible BDI in mind. A BDI not detected 
during the cholecystectomy may be revealed postoperatively either as a bile leakage 
and biloma or later, due to stricture formation, with jaundice and dilated bile ducts. The 
goal of the initial management is control of sepsis and on-going bile leakage with 
antibiotics and the placement of radiologically guided drains into fluid collections. 
Once biliary drainage has been achieved and sepsis controlled, it is often preferable to 
allow the local inflammation to resolve, usually for several weeks, before the definitive 
repair. 
  
A cholangiogram, either by endoscopic retrograde cholangiography (ERC)[197] or 
percutaneous transhepatic cholangiography (PTC) is of fundamental importance prior 
to injury repair as attempts for such without a preoperative cholangiogram have been 
reported to be unsuccessful in 96% of the cases[195]. Moreover, cystic stump leakages 
and minor leakages from peripheral ducts in the liver bed can in the majority of cases 
be handled endoscopically by down-stream control with sphincterotomy or/and stent 
placement[198-200]. Additionally, ERC or PTC with dilatation and stenting is a 
treatment alternative when a BDI presents with jaundice due to stricture formation and 
with the bile ducts still in continuity. In a review of 159 BDI patients treated at the 
Mayo clinic, Rochester, Minnesota, USA, the success rate of endoscopic treatment was 
99% for Strasberg A injuries. Of 66 obstructive Strasberg E1 to E4 injuries, 22 were 
attempted for endoscopic or percutaneous dilatation. Eleven of these patients were 
stented for a median time of 7 months, 8 with excellent result and 3 requiring surgical 
intervention[198]. The results show that endoscopic or percutaneous dilatation therapy 
of strictures is feasible in selected patients, but generally inferior to the success rate of 
surgical reconstruction with Roux-en-y hepaticojejunostomy. The latter being reported 
to have excellent results in 98% of 142 surgically repaired BDI patients at the Johns 
Hopkins Hospital, Baltimore, Maryland, USA[131]. 
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2.2.5.3 Concomitant vascular injuries 
 
Vascular injuries are commonly associated with BDI with incidence estimates 
approximating 25%[201]. The most common injury affects the right hepatic artery 
(>90%)[201], with isolated portal vein injuries and combined portal vein and arterial 
injuries being rare but with the addition of substantial complexity. The 
misinterpretation of the CBD being the cystic duct will result in a cranial dissection 
along the left side of the CBD/CHD with a subsequent division of the CHD in order to 
reach the cystic plate on which the gallbladder rests. The CHD is often divided at the 
location where the right hepatic artery passes under it. Mechanical or thermal trauma is 
usually the cause of damage to the vessel, or clips may be applied in the belief that it is 
the cystic artery. In an autopsy study, as many as 7% of patients having undergone 
cholecystectomy during their lifetime had an injury to the right hepatic artery or its 
branches[202]. It is evident that injuries to the delicate vascularisation of the bile ducts, 
often not obvious during the cholecystectomy, contributes to an upgrading of injury 
severity and could be a determinant of successful or unsuccessful repairs. A BDI in 
combination with injury to the right hepatic artery have been reported to be a predictor 
of restricture after BDI repair with cholangio-enteric anastomosis[127, 203, 204]. 
However, the timing of repair after concomitant vascular injury appears to be 
important. Attempts for an early repair are associated with a high rate of stricture 
development whereas delayed repairs had an excellent success rate[205], a difference 
probably explained by on-going ductal ischemia which have been reported to progress 
for about three months[97]. It has been suggested to routinely evaluate the arteries in 
patients with BDI when planned for early repair. If the right hepatic artery is occluded, 
the performance of a delayed repair, at least 3 months post injury, offers the best 
prognosis[201]. Injuries involving the portal vein or combined portal vein and arterial 
injuries are rare but can cause rapid liver infarction associated with excessive mortality. 
Such injuries require emergent referral to highly experienced hepatobiliar centres.    
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3         AIMS 
 
 
 
The aims of this thesis are: 
 
 
 To investigate the incidence of BDI in Sweden, using a National Quality 
Registry for Gallstone Surgery. 
 
 
 To evaluate the long-term morbidity pattern after BDI, and to assess whether 
liver related diseases or cancer in the liver or bile ducts are overrepresented 
among injured patients. 
 
 
 To estimate the mortality rate after BDI and investigate factors associated with 
increased mortality following BDI. 
 
 
 To address the prevention of BDI by identification of risk factors, with special 
focus on acute cholecystitis and the use of intraoperative cholangiography.    
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4 PATIENTS AND METHODS 
 
 
4.1 THE SWEDISH INPATIENT REGISTRY 
 
Paper I and IV are based on data from the Swedish Inpatient Registry. Since 1965, the 
Swedish National Board of Health and Welfare collects data on individual hospital 
discharges in the Swedish Inpatient Registry. This registry is event based, and 
information on patient demographics, dates of admission and discharge, codes for 
discharge diagnoses, codes for surgical procedures, as well as hospital identification 
codes, are registered. The introduction of the registry was made by region, covering 
10% of all hospital discharges in 1965 with an almost linear increase until 1987, when 
it reached full nationwide coverage. The degree of misclassification in the Swedish 
Inpatient Registry is low with a 94%, validated, agreement for surgical procedure 
codes[206]. 
 
 
4.2 THE SWEDISH REGISTRY FOR GALLSTONE SURGERY  
The Swedish Registry for Gallstone Surgery and Endoscopic Retrograde 
Cholangiopancreatography (ERCP), GallRiks, was founded by the Swedish Surgical 
Society together with the Swedish Society of Upper Abdominal Surgery and the 
Swedish Society of Laparoscopic Surgery in 2005, and is financially supported by the 
Swedish national health authorities. Registration in GallRiks started in May 2005. 
The aim of the registry is to obtain a complete national registration of gallstone 
interventions and to provide continuously updated information regarding indications, 
treatment methods, and complications, as well as patient satisfaction with reference to 
the given treatment. GallRiks covers laparoscopic and open surgery of the gallbladder 
as well as endoscopic interventions of the bile ducts and pancreas, and uses an 
internet platform for online registration. The surgeon or endoscopist reports patient 
characteristics, indications, and choice of surgical method as well as detailed 
information of immediate complications. After 30 days, the medical records are 
reviewed and late complications reported by a local coordinator. 
Since the registry’s founding in 2005, the number of participating hospitals has 
steadily increased, and GallRiks is considered to be completely nationwide, including 
all Swedish centres performing biliary interventions, from 2009 and onwards. 
Comparison with data for registered cholecystectomies in the Swedish Inpatient 
registry, where all diagnosis codes and surgical intervention codes from the 
international classification of diseases (ICD) are registered, shows that the coverage 
rate has increased rapidly since the start of registration in 2005. The coverage rate 
was about 65% in 2006 and has steadily increased since. In 2009 and 2010, 90% of 
Swedish cholecystectomies were registered in GallRiks[207]. 
The data collected in GallRiks are validated on a regular basis by an independent 
audit group that regularly compares registered data with local patient records, both 
validating the data themselves as well as auditing to ensure that adequate resources 
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are assigned for registration and follow-up at each centre. Each hospital has been 
visited once every three years, and a sample of medical records is compared with 
entries of the registry database. GallRiks’ annual report presents the results from 
hospital visits, and the review of the first 1207 medical records at 67 different 
hospitals showed 98% correct registrations[208]. 
 
4.3 PAPER I 
 
4.3.1.1 Study design 
 
A population based cohort study of all cholecystectomies within the Swedish Inpatient 
Registry in the period 1965-2005, aiming to assess survival, factors influencing 
survival and causes of death after reconstructed BDI. 
 
 
4.3.1.2 Definition of bile duct injury cases 
 
The study was limited to persons 15 years or older at the time of cholecystectomy. All 
cholecystectomies registered from 1965 through 2005 were identified (n = 391 937). 
Patients with inconsistent registry data were excluded (n=5879). Patients with 
malignant conditions possibly associated with the reconstruction (n=11 920) were 
identified using linkage to the Swedish National Cancer Registry. Moreover, 96 
reconstructions referring to some benign biliary diagnoses and thus unlikely to be a 
result of BDI were also excluded. In order to define BDI cases, we selected those in the 
cholecystectomy population who during the index procedure, or within one year after it, 
had also undergone any reconstructive biliary procedure, excluding the above described 
cases.  
 
 
4.3.1.3 Statistical analyses 
 
Deaths and causes of death among study subjects were identified by linkage to the 
essentially complete Causes of Death Registry. In the cancer analyses, risk of cancer 
was estimated through linkage with the National Swedish Cancer Registry. 
 
Survival among patients having undergone cholecystectomy, both with and without 
reconstructed iatrogenic BDI, was assessed firstly by the Kaplan-Meier method. 
Survival curves were then adjusted for age, sex and calendar period using a direct 
adjusted method based on a stratified Cox model[209].  
 
The standardized mortality ratio (SMR), the ratio of the observed to the expected 
number of deaths, was used to estimate the relative risk of all-cause and cause-specific 
mortality, here specifically liver disease. The expected number of deaths occurring in 
the entire Swedish population was calculated by multiplying the observed person-time 
by age- (in five year groups), gender- and calendar year-specific mortality rates. The 
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SMRs are thus inherently adjusted for confounding by age at follow-up, gender and 
calendar year. Confidence intervals were calculated assuming that the observed number 
of events followed a Poisson distribution[209].  
 
To compare survival of BDI versus non-BDI, a flexible parametric model was used to 
calculate Hazard ratio (HR) and 95% confidence interval (CI), with adjustments for 
sex, age at cholecystectomy, cholangiography and comorbidity.  
 
Factors influencing survival were analysed using Cox proportional hazards regression 
models to calculate HR with 95% CI.  The follow-up was from the date of 
reconstruction until December 31, 2005. Age was analysed as a continuous variable 
(yearly increase), calendar year as four categories (<1975, 1975-1984, 1985-1994 and 
1995-2005) and method of reconstruction as two categories (direct suture repair and 
cholangio-enteric anastomosis). Comorbid diseases, other diagnoses at discharge from 
the reconstructive procedure hospital-stay that were not related to the procedure or 
complications of it were analysed using the Deyo modification of the Charlson 
comorbidity index[210, 211]. The diagnoses were weighted according to severity using 
the index and then grouped into Charlson score 0, 1 and ≥2, with the latter indicating 
the greatest comorbidity. Hospital type was defined as local, regional or university 
hospital level.  
 
 
 
4.4 PAPER II 
 
4.4.1.1 Study design 
 
A population-based case control study on prospectively collected data from the 
Swedish Registry for Gallstone Surgery and ERCP, GallRiks, with the objective to 
determine factors linked to survival after cholecystectomy. 
 
 
4.4.1.2 Definition of bile duct injury  
   
BDI at cholecystectomy was defined as any tissue damage to the wall of any bile duct 
in the biliary tree, except for injuries to the gallbladder or the intended division of the 
cystic duct, detected during the cholecystectomy or diagnosed postoperatively as a 
result of bile leak or none-stone caused biliary obstruction. Specifically, all types of 
postoperative bile leaks, including leakage from the cystic duct, were included in this 
definition.   
 
 
4.4.1.3 Statistical analyses 
 
Available data of all 51041 cholecystectomies in GallRiks between May 1, 2005 and 
December 31, 2010 were extracted. The data included dates of death during the study 
period, collected from the National Population Registry.  
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Annual incidence rates of peroperatively detected BDI and those detected 
postoperatively (BDI with delayed detection), were calculated.  
 
Survival among patients having undergone cholecystectomy, both with and without 
BDI, as well as by time of BDI detection, was assessed by the Kaplan-Meier method.  
In order to estimate the impact of BDI on survival, as well as to identify risk factors 
affecting survival, Cox proportional hazards regression was used to calculate HR with 
95% CI. End point was all cause death. Sex, age, American Society of 
Anesthesiologists (ASA) classification, planned or emergency operation, hospital 
annual caseload, surgeon annual caseload, BDI and the use of IOC were introduced into 
the model as potential risk factors or confounders of survival. The proportional hazards 
assumption was examined using Shoenfeld’s partial residuals[212]. The presence of 
BDI or not, sex, ASA-classification, planned or emergency operation and IOC did not 
completely fulfil the proportional hazards assumption and were entered in the model 
using the time varying covariate option for the main exposure variable and the strata 
option for potential confounders, i.e. by assuming different baseline hazard for each 
combination of those variables.  The follow-up was from the date of cholecystectomy 
until date of death or end of follow-up on December 31, 2010. Age was analysed as a 
continuous variable (yearly increase) while comorbidity, measured using the ASA 
classification, was categorized as healthy (ASA 1), mild disease (ASA 2) or severely 
impaired health (ASA 3-5). The annual hospital caseload of cholecystectomies was 
dichotomized into low- or high-volume using the close to mean 200 annual 
cholecystectomies (mean=206, median=178). Surgeon annual caseload was similarly 
dichotomized into less or more than 14 (mean=21, median=14) annual 
cholecystectomies.  
 
The use of IOC was dichotomized into performed or attempted IOC as one category 
and not attempted as the other, thus using an intention-to-do approach. In order to 
estimate the impact of IOC on BDI occurrence, a logistic regression model was used, 
adjusting for the same possible confounders as the cox model. Regarding missing data, 
the relative numbers were very low and handled by listwise deletion.   
 
 
4.5 PAPER III 
 
4.5.1.1 Study design 
 
A population-based case control study of cholecystectomised patients within the 
Swedish Registry for Gallstone Surgery and ERCP, GallRiks, aiming for the 
investigation of risk factors for BDI. 
 
 
4.5.1.2 Definition and classification of bile duct injury  
   
In conformity with paper II, A BDI was defined as any tissue damage to the wall of any 
bile duct in the biliary tree, except for injuries to the gallbladder or the intentional 
division of the cystic duct. The injury may be detected during the cholecystectomy or 
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diagnosed postoperatively as a result of bile leak or non-stone caused biliary 
obstruction. Additionally, all types of postoperative bile leaks, including leakage from 
the cystic duct, were classified as BDI in this definition.  
 
When sufficient information regarding injury extent and localization were available, the 
injuries were classified using the Hannover classification[99]. For severity grading, 
injuries commonly requiring reconstructive surgery with cholangio-enteric 
anastomosis, i.e. transectional or obstructive lesions to the common bile duct or 
common hepatic duct as well as lesions above the hepatic confluence were considered 
to be severe. Consequently, lateral incomplete injuries, cystic duct lesions and 
peripheral minor leaks from the gallbladder bed were considered as non-severe. 
 
 
4.5.1.3 Statistical analyses 
 
All cholecystectomies in GallRiks from May 1, 2005 to Dec 31, 2010 were included. 
Factors influencing the risk of BDI were analysed using multivariable logistic 
regression modelling. Each variable was tested univariably and multivariably according 
to purposeful selection as described by Hosmer and Lemeshow[213]. The models were 
tested for multicollinearity, effect modification and finally assessed using the Hosmer-
Lemeshow goodness of fit test. The effects of analysed variables are presented as odds 
ratios (OR) for BDI with 95% CI.  
 
Age was analysed as a continuous variable in the multivariable analysis, but also 
evaluated in categories (<40 years, 40-60 years and >60 years). Body mass index 
(BMI) could be calculated only for a subgroup of patients as this variable was 
introduced into the registry as late as 2010. BMI was categorized into underweight 
(BMI <18.5), normal (BMI 18.5-25), overweight (BMI 25-30) and obese (BMI >30) 
according to WHO definition[214]. Comorbidity was studied using ASA score, 
grouped as healthy (ASA 1), mild comorbidity (ASA 2) and severe comorbidity (ASA 
3-5). The presence of acute cholecystitis or not is a specified variable within GallRiks 
and is determined by the reporting surgeon on clinical evidence, not by pathology 
report. Within the subgroup of patients with acute cholecystitis, the number of days 
from admission until surgery was used as a proxy for time of symptom onset to the 
time of operation and labeled cholecystectomy timing. Cholecystectomy timing was 
analysed as a continuous variable within the subgroup of patients with acute 
cholecystitis. The variables emergency/planned admission and acute cholecystitis were 
introduced into the model separately because they were collinear, but only the one 
representing the greatest confounding effect was retained in the model. The annual 
caseload of cholecystectomies was evaluated as a continuous variable in the regression 
models but presented categorized into low volume (< 10 per surgeon, < 100 per 
hospital), medium volume (10-40 per surgeon, 100-200 per hospital) and high volume 
(>40 per surgeon, >200 per hospital). The use of IOC was categorized into 1. Not 
intended, 2. Performed, 3. Intended but failed and finally 4. Intention to do (both 
performed and intended but failed together). 
 
 34 
BMI was excluded from the multivariable model due to the amount of missing data 
BMI (>85%). For the remaining variables, the proportions of missing values were 
small. Missing values were therefore handled using listwise deletion. 
 
 
4.6 PAPER IV 
 
4.6.1.1 Study design 
 
A matched, nested and population based case control study evaluating the impact of 
gallbladder inflammation on BDI risk.  
 
 
4.6.1.2 Definition of cases and control 
 
The study was limited to persons 15 years or older with a cholecystectomy performed 
between the years of 1990 to 2005. For practical purposes concerning medical record 
review, only cases and controls within the geographically restricted area of the five 
counties of the Lake Mälaren Valley in central eastern Sweden were included.  
Potential iatrogenic BDI cases were defined as a cholecystectomy with a procedure 
code representing biliary reconstruction within one year after removal of the 
gallbladder. To avoid other causes for biliary reconstruction, patients with a 
concomitant cancer diagnosis within two years of the index event or a diagnosis code 
representing a few benign conditions potentially treated with biliary reconstruction 
were excluded.  
 
Control patients were defined as cholecystectomies without reconstructive biliary 
events, matched to cases on gender, age and year of cholecystectomy and randomly 
sampled to a case to control-ratio of 1:3. 
 
 
4.6.1.3 Data collection 
 
In accordance with the ethical approval, informed consent was sent out to living 
participants authorizing medical record review. Thirty-eight patients (10 cases and 28 
controls) denied review. 
Remaining cases´ and controls´ medical records were reviewed regarding patient and 
procedure related variables with hypothesized relation to BDI and gathered in a 
Microsoft Access
®
 database. 
With this procedure-code methodology, 50 potential BDI cases were wrongly identified 
as bile duct injuries and thus excluded. Furthermore, 14 potential cases and 45 controls 
were either inaccessible (due to deletion of patient records) or lacked sufficient 
information regarding surgery, injury extent or complications and were therefore 
excluded. Remaining cases and controls were included in the final analyses. 
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4.6.1.4 Acute cholecystitis and the 2013 Tokyo guidelines 
 
The diagnosis of acute cholecystitis was made according to the 2013 revision of the 
Tokyo Guidelines for acute cholecystitis[41] (TG13). In order to meet the criteria of 
acute cholecystitis, the patient needs local signs of inflammation (Murphy’s sign or 
right upper quadrant mass/pain/tenderness) as well as systemic signs (fever or elevated 
CRP/WBC count). According to TG13, a definite diagnosis of acute cholecystitis also 
requires a characteristic finding on imaging (ultrasound/CT/MRI). As the diagnosis of 
acute cholecystitis among cases and controls sometimes was made without imaging 
confirmation, the TG13 criteria of suspected diagnosis were used to define acute 
cholecystitis. Patients with acute cholecystitis were subsequently graded according to 
the TG13 severity assessment into mild (grade I), moderate (grade II) or severe (grade 
III). 
 
 
4.6.1.5 Statistical analyses 
 
As 147 of either cases or controls were excluded due to the above stated reasons, the 
loss of power caused by exclusion of incomplete pairs would have been considerable. 
This was handled by breaking the match and using unconditional logistic regression, 
controlling for the matched variables (age, gender, and year of cholecystectomy).  
Possible risk factors for BDI were tested univariably and multivariably using 
purposeful selection described by Hosmer and Lemeshow[213]. Age, BMI and CRP 
were treated as continuous variables in the models. BMI was presented as categorized 
into underweight (BMI < 18.5), normal (BMI 18.5-25), overweight (BMI 25-30) and 
obesity (BMI > 30) according to the WHO-definition[214]. BMI was not measurable in 
29% of the patients, with missing values evenly distributed among cases and controls. 
The crude estimate of the effect of BMI on BDI was non-significant and BMI was thus 
not included in the multivariable model.  Comorbidity was analysed using the Deyo 
modification of the Charlson comorbidity index[211]. The duration of symptomatic 
gallstone disease was estimated either from information available in the admission 
records or if missing, from a possible previous gallstone diagnosis in the Swedish 
Inpatient Registry. The time period was divided into three categories: symptomatic 
gallstone disease less than 1 year, 1-5 years or longer than 5 years. The duration of 
symptoms could not be found in 7% of the journals or records, and missing values was 
handled by listwise deletion. Due to significant collinearity between acute cholecystitis 
and emergency operation, these variables were analysed in separate models, and only 
acute cholecystitis was used for confounder adjustment. As CRP was not used on a 
regular basis during the early 1990
ies
 and usually only on patients with inflammation, 
87% of elective cholecystectomies and 25% of patients with acute cholecystitis had 
missing values. The impact of CRP on BDI risk was thus investigated only in a 
subgroup of patients with acute cholecystitis and was not used for confounder 
adjustment. A Receiver Operating Characteristic (ROC) statistic was performed 
measuring the predictive value of CRP on BDI risk among patients with acute 
cholecystitis. The presence of CBDS was defined as suspected stone(s) on IOC. As the 
frequency of CBDS among patients without IOC (32%) was unknown, a subanalysis on 
patients with successful cholangiography data was performed. CBDS were 
subsequently not used for confounder adjustment.   
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The final models were tested for effect modification and assessed using Hosmer-
Lemeshow goodness of fit test. OR for BDI were presented with 95% CI and p-values 
< 0.05 were considered to be significant. 
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5 RESULTS 
 
5.1 PAPER I 
A total of 374 042 cholecystectomies were identified during the years of 1965-2005. 
Among these, 1386 cases of iatrogenic BDI requiring surgical reconstruction within 
one year of the cholecystectomy were identified. A majority, 251 423 (67.5%) of the 
cholecystectomies, were performed in women, while 795 (57.4%) of the reconstructed 
BDI occurred in women. The mean age at the time of cholecystectomy was for all 
study subjects 52.6 years and for BDI cases 59.9 years 
 
 
5.1.1.1 Long term survival after bile duct injury    
 
The Kaplan-Meier survival curves showed an overall significantly lower survival 
among patients with reconstructed iatrogenic BDI compared to non-injured, with a one 
year mortality of 15,8% (Figure 5). After adjustments for age, sex and calendar year, 
survival in the BDI group was 9.8% (95% CI 8.7% - 10.9%) lower than that of patients 
without injury during the first year following operation, whereas long-term survival 
was similar. This change after adjustment was mainly due to the confounding effect of 
age. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 5. Kaplan-Meier survival curves and survival curves adjusted for sex, age and 
calendar year of cholecystectomy for patients with and without reconstructed BDI. 
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HR for death at three months, one, three and five years after cholecystectomy were 5.52 
(95% CI 4.80-6.34), 3.73 (95% CI 3.30-4.22), 1.90 (95% CI 1.70-2.12) and 1.58 (95% 
CI 1.42-1.76), respectively among BDI patients. After seven years the relative risk 
gradually evened out. 
 
 
5.1.1.2 Causes of death after bile duct injury 
 
Within the first year after the cholecystectomy the overall adjusted SMR, was 7.39 
(95% CI 6.42-8.47) for reconstructed BDI patients, compared to 1.45 (95% CI 1.41-
1.48) in the non-injured group. The risk of dying from liver diseases of any kind in the 
BDI cohort was estimated to be 4.37 (95% CI 1.88-8.60) times that of the general 
population with cirrhosis of the liver 2.68 (95% CI 0.73-6.87) or cholangitis 62.9 (95% 
CI 17.1-161) as the most common registered causes of death (Table 5). 
 
Table 5. SMRs for all causes, as well as for hepatobiliary diseases among patients with 
or without BDI. 
  
Non-BDI 
 
BDI 
  Duration Observed SMRa (95% CI)   Observed 
SMR
a
 (95% 
CI) 
All causes Entire follow-up period 116,208 1.01 (1.00–1.01) 
 
630 1.76 (1.63–1.90) 
 
<1 y 17,91 1.45 (1.41–1.48) 
 
208 7.39 (6.42–8.47) 
 
1–4 y 6827 0.90 (0.89–0.92) 
 
155 1.72 (1.46–2.01) 
 
>5 y 91,471 1.01 (1.00–1.01) 
 
267 1.11 (0.98–1.26) 
All liver diseases Entire follow-up period 978 1.54 (1.44–1.64) 
 
8 4.37 (1.88–8.60) 
Cirrhosis Entire follow-up period 876 1.42 (1.32–1.52) 
 
4 2.68 (0.73–6.87) 
Cholangitis Entire follow-up period 38 2.00 (1.41–2.74) 
 
4 62.9 (17.1–161) 
Acute liver failure Entire follow-up period 37 1.15 (0.81–1.59)   0 — 
aThe Swedish general population was used as a reference. 
    SMR, standardized mortality ratio. 
 
     
 
SIR (Standardized Incidence Ratio, the observed number of cancers divided by the 
expected number) for cancer in the liver and bile ducts was 0.56 (95% CI: 0.51-0.61) 
among patients with cholecystectomy without BDI during the follow-up period 
compared to 1.61 (95% CI: 0.44-4.12) in the BDI group. As the expected number of 
cancer cases in the BDI group was very small (only 2.5) the cohort was too small for 
any analyses with acceptable precision. 
 
 
5.1.1.3 Factors influencing survival after BDI   
 
Sex did not appear to affect survival after BDI in the multivariate analyses, but there 
was a significant and gradual decrease in relative survival with increasing age at the 
time of injury. In comparing the defined calendar periods, no difference in 
survival after BDI was seen. The adjusted HR for death after reconstruction by 
cholangioenteric anastomosis, with suture reconstruction as the reference category, 
was 1.48 (95% CI, 1.23–1.79).  
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There was a dose-dependent association between increasing Charlson comorbidity 
score and the risk of not surviving after reconstructed iatrogenic BDI. No difference 
in survival was seen whether the reconstructive surgery was performed on the same 
date as the cholecystectomy, as in 85% of the cases, or on a later date, as in 15% of 
the cases. IOC was used in 780 (56%) of the 1386 cases of BDI. In the multivariate 
adjusted model, the use of an IOC indicated improved survival with a HR of 0.73 
(95% CI, 0.62–0.86) compared with BDI cases in which IOC was not performed. 
Survival after reconstructed BDI was not affected by the hospital type where the 
reconstructive procedure was performed or by the hospital caseload of 
cholecystectomies at the hospital where the cholecystectomy was performed. Factors 
influencing the survival after BDI are displayed in Table 6. 
 
Table 6. Factors influencing the survival after reconstructed BDI. 
 
  
Hazard Ratio for death after BDI 
  Frequency* Crude HR Adjusted HR 
Gender 
   
  Women 794 1.0 (reference) 1.0 (reference) 
  Men 590 1.56 (1.33-1.81) 1.07 (0.92-1.25) 
Age 
   
  per yearly increase 1384 1.08 (1.07-1.08) 1.07 (1.06-1.07) 
Calendar year 
   
  < 1975 112 1.0 (reference) 1.0 (reference) 
  1975-1984 294 1.24 (0.94-1.64) 0.81 (0.61-1.08) 
  1985-1994 380 1.60 (1.20-2.12) 0.93 (0.68-1.26) 
  1995-2005 598 1.30 (0.96-1.76) 1.09 (0.78-1.52) 
Method of reconstruction 
   
  Suture 585 1.0 (reference) 1.0 (reference) 
  Cholangio-enteric  anastomosis 799 2.39 (2.01-2.83) 1.48 (1.23-1.79) 
Comorbid diseases 
   
  Charlson score = 0 508 1.0 (reference) 1.0 (reference) 
  Charlson score = 1 335 1.19 (0.93-1.53) 1.22 (0.94-1.60) 
  Charlson score >= 2 541 3.14 (2.54-3.87) 2.19 (1.75-2.75) 
Reconstruction timing 
   
  On the cholecystectomy date 1182 1.0 (reference) 1.0 (reference) 
  On a later date 202 0.60 (0.46-0.77) 0.82 (0.63-1.07) 
IOC 
   
  No 606 1.0 (reference) 1.0 (reference) 
  Yes 778 0.44 (0.38-0.52) 0.73 (0.62-0.86) 
Hospital type 
   
  University 301 1.0 (reference) 1.0 (reference) 
  Regional 437 0.94 (0.76-1.17) 1.00 (0.80-1.24) 
  Local 646 1.01 (0.83-1.23) 1.09 (0.87-1.36) 
Hospital case load, per year 
   
  >200  367 1.0 (reference) 1.0 (reference) 
  100-200 455 0.78 (0.65-0.95) 0.90 (0.73-1.11) 
  <100 562 0.84 (0.70-1.02) 0.87 (0.70-1.09) 
* Two patients had cholecystectomies in 2005 and had reconstructions in 2006, which was after the end of follow-up (December 31, 
2005), and were therefore excluded from further analysis.  
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5.2 PAPER II 
 
Between May 1, 2005 and December 31, 2010, 51041 cholecystectomies were 
registered in the Swedish Registry for Gallstone Surgery and ERCP, GallRiks. In total, 
747 BDI, were detected, corresponding to a cumulative incidence of 1.5%. There was 
no significant difference in BDI incidence between sexes, but the mean age of patients 
suffering an injury to the bile ducts was slightly higher, 55.2 years (95% CI 54.0 - 
56.3), compared to non-injured, 50.7 years (95% CI 50.5 - 50.8). 
 
A minority, 23% (170) of BDI, were detected and classified during the primary 
cholecystectomy whereas in 77% (577) detection was delayed, occurring in the 
postoperative period.  
 
Annual distribution of registered cholecystectomies in GallRiks, together with 
peroperative and delayed detected BDI, are presented in Table 7. 
 
 
Table 7. Cholecystectomies and annual incidence of BDI in the Swedish Registry for 
Gallstone Surgery and ERCP, GallRiks. 
                   
 
 
BDI 
Year Cholecystectomies (n) Early detection
a
 (%) Delayed detection
b
 (%) Total (%) 
2005
c
 1113 1 (0.1) 7 (0.6) 8 (0.7) 
2006 7680 36 (0.5) 81 (1.1) 117 (1.5) 
2007 8931 21 (0.2) 94 (1.1) 114 (1.3) 
2008 10350 35 (0.3) 135 (1.3) 170 (1.6) 
2009 11823 44 (0.4) 126 (1.1) 170 (1.6) 
2010 11144 33 (0.3) 134 (1.2) 167 (1.5) 
Total 51041 170 (0.3) 577 (1.1) 747 (1.5) 
a BDI detected during cholecystectomy 
   b BDI detected after cholecystectomy 
   c May 1 - December 31 2005 
    
 
5.2.1.1 Severity of bile duct injuries 
 
Among severe BDI, 85% (n=41) were detected during the primary cholecystectomy. 
Among peroperatively detected lesions, 24% were correspondingly considered to be 
severe. A majority of BDI detected postoperatively were discovered as bile leakage, 
either from the cystic duct (46%) or from small ducts in the liver bed (18%), whereas 
only 2% (n=14) of injuries with delayed detection were considered to be severe. 
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5.2.1.2 Survival after 
cholecystectomy 
 
The Kaplan-Meier survival curves 
show an overall significantly lower 
survival among patients with BDI 
compared to non-injured patients 
after cholecystectomy,  with a one 
year mortality of 3.9% compared to 
1,1% among non-injured.  
See Figure 6.  
 
Figure 6. Kaplan-Meier survival curve for 
patients with and without BDI 
 
 
Comparing peroperatively detected 
BDI, with delayed detected, the 
Kaplan-Meier survival curves show 
impaired survival in the delayed-
detection group. Peroperatively 
detected injuries had a survival not 
differing significantly from that of 
non-injured subjects undergoing 
cholecystectomy. See Figure 7. 
 
 
 
Figure 7. Survival probability of patients after 
cholecystectomy in relation to no injury, early 
detected BDI and delayed detected BDI 
 
 
Analysing the cohort of patients 
suffering BDI with the Kaplan-Meier 
method, injured patients operated 
with the use, or attempt for use, of 
IOC had a significantly improved 
survival compared to injured patients 
where IOC was not attempted. See 
Figure 8.   
  
 
 
 
Figure 8. Survival among patients suffering 
iatrogenic BDI during cholecystectomy, stratified 
according to the use of IOC or not. 
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5.2.1.3 Factors influencing survival after cholecystectomy 
 
The cox regression analysis showed a close to two-fold hazard of dying among injured 
patients compared to non-injured, during the first year (HR 1.92 95% CI1.24-2.97). 
When detection time was taken into consideration, injuries with delayed detection had a 
statistically significant approximately two-fold hazard of dying compared to non-
injured (HR 1.95 95% CI 1.12-3.37). High age, increased ASA score and emergency 
operation were all associated to impaired survival after cholecystectomy in the 
multivariate model, whereas surgery at a hospital with annual cholecystectomy 
volumes of more than 200 was associated with improved survival.  
The intention to use IOC significantly reduced the hazard of dying after 
cholecystectomy with 62% (HR 0.38 95% CI 0.31 – 0.46). See Table 8. 
 
 
Table 8. Cox proportional hazard model. Survival and factors influencing survival 
after cholecystectomy. 
   
Hazard Ratio (95% CI) 
Variables     Crude  Adjusted
c
 
Age (per yearly increase) 
  
1.10 (1.09-1.10) 1.07 (1.07-1.08) 
Sex                                                 Male 
 
1.0 (ref) 1.0 (ref) 
 
Female 
 
0.48 (0.43-0.54) 0.85 (0.72-1.01) 
ASA score*                                         1 
 
1.0 (ref) 1.0 (ref) 
 
2 
 
5.04 (4.29-5.92) 2.65 (2.11-3.34) 
 
3-5 
 
23.46 (19.89-27.67) 9.76 (7.17-13.28) 
Surgery*                               Planned 
 
1.0 (ref) 1.0 (ref) 
Emergency 
 
2.49 (2.23-2.78) 2.05 (1.69-2.49) 
Surgeon´s annual caseload
a
      < 14 
 
1.0 (ref) 1.0 (ref) 
>14 
 
0.89 (0.80-1.00) 0.90 (0.82-1.01) 
Hospital annual caseload
b 
      < 200 
 
1.0 (ref) 1.0 (ref) 
      > 200 
 
0.77 (0.69-0.86) 0.86 (0.76-0.97) 
Bile duct injury (BDI)*           No BDI 
 
1.0 (ref) 1.0 (ref) 
 
          BDI 
 
2.57 (1.91-3.46) 1.92 (1.24-2.97) 
Early detection of BDI 
 
1.17 (0.49-2.82) 0.71 (0.21-2.40) 
Delayed detection of BDI 
 
3.02 (2.20-4.14) 1.95 (1.12-3.37) 
IOC*                           Not performed 
 
1.0 (ref) 1.0 (ref) 
Performed 
 
0.42 (0.37-0.48) 0.38 (0.31-0.45) 
Attempted but interrupted 
 
0.51 (0.36-0.70) 0.36 (0.23-0.54) 
Intended   0.44 (0.38-0.50) 0.38 (0.31-0.46) 
* Variables with sign of non-proportional hazards according to Schoenfeld residuals. Variables were thus treated as a time varying 
and the HR should be interpreted as the effect during the first year 
a Median: 14 annual cholecystectomies/surgeon. A complementary analysis comparing high volume (more than 40 annual 
operations) to low volume (less than 10 annual operations) did not show significant survival differences, data not shown. 
b Mean: 201 cholecystectomies/year 
c Derived from a Cox regression model, mutually adjusted for variables listed in the table. 
 
   43 
5.3 PAPER III 
During the period May 1, 2005 to Dec 31 2010, 51 041 cholecystectomies were 
registered in GallRiks. Among these, 747 (1.46%) patients suffered an iatrogenic bile 
duct injury. The localization and extent of injuries are described in Figure 9. Of the 
51 041 cholecystectomies 15 462 (30%) were operated under non-elective conditions 
and 9 008 (18%) were diagnosed with acute cholecystitis. There was a history of 
previous acute cholecystitis in 5787 of the operated patients (11%). Laparoscopic 
approach was used in 44 241 (90%) of the operations with a conversion rate of 9%. 
Patients with elective settings had a laparoscopic approach in 95% of the cases 
compared to 77% within the emergent surgery group.   
 
 
Figure 9. Distribution of 747 bile duct injuries among 51 041 cholecystectomies in 
GallRiks. 
  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Location Type of injury Hannover N 
A Cystic duct lesion/leakage A1 265 
B 
Lesion to peripheral ducts in the region of the 
gallbladder bed 
A2 106 
C 
Tangential lesion of the common bile duct C1, C2, C3 130 
Completely transected bile duct (at or below 
the hepatic bifurcation) 
D1, D2, D3 16 
Obstructive injuries B1, B2 7 
D Lesions above the hepatic confluence C4, D4 32 
 Injuries without sufficient information 
regarding location or extent. 
 191 
    
  
Total: 747 
A 
B 
C 
D 
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5.3.1.1 Risk factors for bile duct injury 
 
There was no difference in the risk of BDI during cholecystectomy between men and 
women whereas increased age and comorbidity (represented by ASA-score) were 
independent and significant risk factors for injury. Among the subgroup of patients 
with data on BMI, there was no significant association between BMI and risk of BDI. 
 
Table 9. Odds ratio for BDI during cholecystectomy according to possible risk factors. 
 
 
Odds ratio for bile duct injury at cholecystectomy 
Variable Crude Adjusted
a
 
Age 
  Per yearly increase 1.02 (1.01-1.02) 1.01 (1.01-1.02) 
< 40 years 1.0 (ref) 1.0 ref 
40-60 years 1.63 (1.32-2.00) 1.53 (1.24-1.89) 
> 60  years 1.99 (1.62-2.44) 1.61 (1.28-2.02) 
Sex 
       Male 1.0 (ref) 1.0 ref 
     Female 0 .86   (0.74- 1.00) 0.95 (0.81-1.11) 
BMI
b
 
  Slim (BMI < 20) 1.03 (0.13-7.62) 0.85 (0.11-6.42) 
Normal (BMI 20-25) 1.0 (ref) 1.0 (ref) 
Overweight (BMI 25-30) 0.91 (0.60-1.40) 0.85 (0.55-1.31) 
Obese (BMI <30) 0.92 (0.59-1.45) 0.91 (0.57-1.44) 
ASA classification 
       ASA 1 1.0 (ref) 1.0 ref 
     ASA 2 1.44 (1.24-1.68) 1.18 (0.99-1.40) 
     ASA 3-5 1.99 (1.56-2.53) 1.33 (1.01-1.75) 
Admission 
       Planned 1.0 (ref) 1.0 ref 
     Emergency 1.43 (1.23-1.66) 1.41 (1.21-1.64) 
Surgical method 
       Laparoscopic 1.0 (ref) 1.0 (ref) 
     Open 2.10 (1.74-2.54) 1.56 (1.26-1.94) 
Acute cholecystitis 
       No 1.0 (ref) 1.0 (ref) 
     Yes 1.40 (1.18-1.67) 1.23 (1.03-1.47) 
History of cholecystitis   
       No 1.0 (ref) 1.0 (ref) 
     Yes 1.54 (1.26-1.87) 1.34 (1.10-1.64) 
Common bile duct stone(s)
c
 
  No 1.0 (ref) 1.0 (ref) 
Yes 1.62 (1.31-2.01) 1.51 (1.22-1.88) 
Intraoperative cholangiography
d
 
  Not performed 1.0 (ref) 1.0 (ref) 
Performed 0.69 (0.57-0.85) 0.71 (0.58-0.87) 
Attempted, but interrupted 1.13 (0.80-1.59) 1.14 (0.79-1.63) 
Intention to do  0.71 (0.59-0.87) 0.76 (0.62-0.93) 
Surgeon´s annual caseload 
  Low volume (< 10) 1.0 (ref) 1.0 (ref) 
Medium volume (10-40) 1.05 (0.90-1.23) 1.10 (0.94-1.28) 
High volume (>40) 0.89 (0.70-1.13) 0.91 (0.71-1.18) 
Hospital´s annual caseload 
  Low volume (<100) 1.0 (ref) 1.0 (ref) 
Medium volume (100-200) 1.15 (0.94-1.42) 1.03 (0.85-1.25) 
High volume (>200) 0.99 (0.81-1.21) 1.10 (0.91-1.33) 
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a Adjusted for age (continuous variable), gender, ASA-classification, admission, acute cholecystitis, history of 
cholecystitis, surgical method, intraoperative cholangiography, surgeon´s caseload,(continuous variable) 
hospital´s caseload (continuous variable). All models showed satisfactory goodness of fit according to Hosmer 
and Lemeshow Goodness of fit test. 
 
b Due to the large number of missing data was BMI not used in the multiadjusted model. 
 
c Common bile duct stones detected during intraoperative cholangiography. Due to the relative large number of 
missing data (no successful cholangiography) and the subsequent risk of differential misclassification bias was 
common bile duct stones not used for confounder adjustment.  
 
d Previously presented data: Törnqvist et. al. Effect of intended intraoperative cholangiography and early 
detection of bile duct injury on survival after cholecystectomy: population based cohort study, BMJ 2012;; 
345:e6457 
 
 
5.3.1.1.1 Acute cholecystitis and the risk of bile duct injury 
 
Patients with acute cholecystitis had a 23% increased risk of BDI (OR 1.23 (95% CI 
1.03-1.47)). Patients with a history of acute cholecystitis but no on-going inflammation 
at time of surgery were similarly at higher risk with OR for injury at 1.34 (95% CI 
1.10-1.64) (Table 9). Compared with no cholecystitis, the odds ratio for severe and 
non-severe BDI associated with acute cholecystitis were 1.93 (95% OR 1.03-3.60) and 
1.20 (95% CI 0.99-1.44), respectively (data not tabulated). 
 
The risk of bile duct injury had an increasing, but non-significant trend, for every added 
day between admission and cholecystectomy among patients with acute cholecystitis, 
(p=0.38). When stratified by severity of the BDI the association with time since 
admission was attenuated and significant for severe injuries OR 1.15 (95% CI 1.01-
1.31) but remained non-significant for non-severe injuries OR 1.01 (95% CI 0.94-1.09). 
 
An intended IOC was associated with a 56% reduced risk of BDI among patients with 
on-going acute cholecystitis (OR 0.44 (95% CI 0.30-0.63)). Patients with a history of 
acute cholecystitis had a border significant risk reduction of 41% (OR 0.59 (95% CI 
0.35-1.00)). Patients without a history of cholecystitis and without present acute 
inflammation did not have a risk reduction with the use of IOC (Table 10).  
 
 
Table 10. The effect of IOC intention among patients with and without acute 
cholecystitis. 
  
Adjusted
a
 odds ratio for BDI 
Peroperative condition IOC success rate No IOC Intention-to-do IOC 
Present acute cholecystitis 94.1% 1.0 (ref) 0.44 (0.30-0.63)  
History of acute cholecystitis 96.1% 1.0 (ref) 0.59 (0.35-1.00) 
No acute cholecystitis and no 
history of acute cholecystitis 
97.8% 1.0 (ref) 0.97 (0.74-1.25) 
a Adjusted for possible confounders using the same models as in table 9 
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5.4 PAPER IV 
 
Using the methodology described in the method section, 232 cases of cholecystectomy 
with biliary reconstruction and 696 controls were identified within the defined 
catchment area study base. After collection of medical records, 158 BDI cases and 623 
controls remained for statistical analyses.  
 
Of the 158 reconstructed BDI cases, 10.8% (n=17) were complete transections of the 
CBD or CHD. 15.8% (n=25) of the injuries were transections or major tangential 
injuries to bile ducts above the hepatic confluence. A majority, 68.9% (n=109), of the 
injuries consisted of lateral incomplete lesions to the CBD or CHD.  Nine injuries (6%) 
had a peroperatively discovered concomitant vascular injury to the right hepatic artery. 
A majority, 80%, of the injuries were discovered during cholecystectomy with the 
remaining discovered at a median of 7 days post cholecystectomy (range 1-250 days). 
A detailed description of BDI pattern, classified according to the Hannover 
classification is presented in table 11, and characteristics among cases and controls in 
table 12. 
 
 
Table 11. Distribution of BDI according to the Hannover classification. 
 
Hannover classification N (with vascular injury) 
Peripheral leakage 
 
A1 - Cystic duct leak 2 
A2 - Leak in the gallbladder bed 0 
Biliary tract occlusion 
 
B1 - Incomplete 3 
B2 - Complete 0 
Tangential injury 
 
C1 - Lesion < 5 mm 73 (1) 
C2 - Lesion > 5 mm below hepatic confluence 34 (1) 
C3 - Extensive lesion at hepatic confluence 2 
C4 - Extensive lesion above hepatic confluence 11 (2) 
Complete transection 
 
D1 - Without defect below hepatic confluence 6 
D2 - With defect below hepatic confluence 7 (2) 
D3 - At hepatic confluence 4 (1) 
D4 - Above hepatic confluence 14 (2) 
Late stenosis 
 
E1 - Main bile duct, short < 5 mm 0 
E2 - Main bile duct, > 5 mm 2 
E3 - At hepatic confluence 0 
E4 - Above hepatic confluence 0 
Total 158 (9) 
      
 
 
   47 
 
Table 12. Characteristics of cases and controls. 
 
Variable Cases (N=158) Controls (N=623) Missing values 
Gender
a
 
  
0 
Male (%) 75 (47%) 309 (50%) 
 
Female (%) 83 (53%) 314 (50%) 
 
Age
a
, mean (SD) 58.6 (16.5) 61.3 (15.7) 0 
BMI, mean (SD) 27.2 (4.40) 26.3 (4.19) 229 
Comorbidity (Charlson index) 
  
0 
0 84 (53%) 435 (70%) 
 
1 30 (19%) 103 (17%) 
 
2 44 (28%) 85 (13%) 
 
Years with gallstone disease 
  
55 
>1 years (%) 46 (29%) 253 (41%) 
 
1-5 years (%) 52 (33%) 239 (38%) 
 
> 5 years (%) 44 (28%) 92 (15%) 
 
Cholecystectomy settings 
  
0 
Laparoscopic (%) 130 (82%) 499 (80%) 
 
Open (%) 28 (18%) 124 (20%) 
 
Emergency (%) 61 (39%) 166 (27%) 
 
Planned (%) 97 (61%) 457 (73%) 
 
Acute cholecystitis (%) 40 (25%) 104 (17%) 
 
CRP
b
, mean (SD) 163 (91) 121 (95) 590b 
CRP < 10 1 (3%) 4 (5%) 
 
CRP 10 - 100 9 (30%) 38 (49%) 
 
CRP > 100 20 (67%) 36 (46%) 
 
Acute cholecystitis in the medical history (%) 40 (25%) 92 (15%) 0 
Acute pancreatitis (%) 3 (2%) 15 (2%) 0 
Acute pancreatitis in the medical history (%) 16 (10%) 60 (10%) 0 
Common bile duct stones (%) 15 (13%) 47 (11%) 251c 
Intraoperative cholangiography (IOC) 
  
0 
No (%) 30 (19%) 184 (29%) 
 
Yes (%) 120 (76%) 410 (66%) 
 
Attempted, but failed IOC (%) 8 (5%) 29 (5%) 
 
IOC To confirm BDI
d
 (%) 29 (18%) * 
 
IOC intention
e
 (%) 99 (62%) 439 (70%)   
a Matching variables 
  
b CRP among patients with acute cholecystitis (36 missing values in this group) 
 
c Patients without conclusive IOC 
  
d IOC (to confirm BDI) after complete division of suspected cystic duct 
 
e Intention to do IOC, consists of: performed IOC and attempted but failed IOC but not cases where IOC was 
used to confirm BDI. 
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5.4.1.1 Severity of acute cholecystitis and the risk of bile duct injury   
 
Among the BDI cases, 25% (n=40) had on-going acute cholecystitis. The 
corresponding figure among controls was 17% (n=104). The severity distribution of 
acute cholecystitis among cases and controls, according to the Tokyo guidelines 
(TG13), are presented in table 13. 
 
 
Table 13. Severity assessment according to the 2013 Tokyo Guidelines. 
 
Tokyo grade for acute cholecystitis Cases Controls 
Mild (grade I)  
13 53 
Does not meet the criteria of grade II or III 
Moderate (grade II)  
25 49 
Associated with any one of the following conditions: 
1. Elevated WBC count (>18 000/mm
3
) 
2. Palpable tender mass in the right upper abdominal quadrant 
3. Duration of complaints >72 h 
4. Marked local inflammation  
Severe (grade III)  
2 2 
Associated with dysfunction of any one of the following 
organs/systems 
1. Cardiovascular dysfunction  (Hypotension requiring treatment with 
dopamine <5 μg/kg per min, or any dose of norepinephrine 
2. Neurological dysfunction (decreased level of consciousness) 
3. Respiratory dysfunction (PaO2/FiO2 ratio <300) 
4. Renal dysfunction (oliguria, creatinine >2.0 mg/dl (>180 μmol/L)) 
5. Hepatic dysfunction (PT-INR > 1.5) 
6. Haematological dysfunction (platelet count <100 000/mm
3
) 
  
 
The adjusted risk of BDI was close to doubled among patients with on-going acute 
cholecystitis (OR 1.97 95% CI 1.05 to 3.72). Furthermore, patients with a former 
diagnosis of acute cholecystitis had more than three times the risk of a BDI in the 
subsequent cholecystectomy compared to patients without a former cholecystitis 
diagnosis (OR 3.63 95% CI 2.00 to 6.57). Increased severity of acute cholecystitis was 
associated with a corresponding increase in injury risk. Whereas a mild acute 
cholecystitis (Tokyo grade I) did not significantly increase the risk of injury (OR 0.96 
95% CI 0.41 to 2.25), a moderate cholecystitis (Tokyo grade II) more than doubled the 
risk (OR 2.41 95% CI 1.21 to 4.80). Additionally, a trend towards even higher risk was 
seen among the most severe cases of acute cholecystitis (OR 8.43 95% CI 0.97 to 72.9). 
 
Within the acute cholecystitis group, CRP showed a linear trend with a small increase 
in injury risk corresponding to an increase of one unit of CRP. The ROC - area under 
the curve regarding CRP was 0.64 (data not shown). 
 
The detailed results of the multivariate regression are listed in table 14. 
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Table 14. Logistic regression with odds ratios for reconstructed BDI at 
cholecystectomy. 
 
 
Odds ratio for BDI (95% CI)  
Variable Crude   Adjusted
a 
  
Gender * * 
Age * * 
BMI               per unit increase 1.04 (0.99-1.10) 1.02 (0.97-1.08)
b
 
Underweight (BMI < 18.5) 1.21 (0.13-11.2) 1.67 (0.16-18.1)
b
 
Normal (BMI 18.5-25) (ref) 1.0 (ref)  1.0 (ref) 
Overweight (25-30) 1.25 (0.78-2.02) 1.25 (0.73-2.12)
b
 
Obese (BMI > 30) 1.73 (0.98-3.06) 1.53 (0.82-2.88)
b
 
Comorbidity (Charlson index) 
  0 (ref) 1.0 (ref)  1.0 (ref) 
1 1.90 (0.72-1.49) 1.70 (0.85-3.38) 
2 3.77 (2.33-6.08) 3.71 (1.96-7.01) 
Years with gallstone disease 
  <1 years (ref) 1.0 (ref)  1.0 (ref) 
1-5 years  1.21 (0.78-1.88) 1.24 (0.70-2.21) 
> 5 years  2.96 (1.80-4.88)  2.88 (1.51-5.48) 
Cholecystectomy 
  Laparoscopic (ref) 1.0 (ref)  1.0 (ref) 
Open  0.95 (0.60-1.51) 0.93 (0.47-1.84) 
Planned (ref) 1.0 (ref)  1.0 (ref) 
Emergency  1.88 (1.29-2.74) 2.62 (1.46-4.72) 
Acute cholecystitis 
  No (ref) 1.0 (ref)  1.0 (ref) 
Yes 1.94 (1.25-2.99) 1.97 (1.05-3.72) 
Tokyo grade I (mild) 1.22 (0.63-2.33) 0.96 (0.41-2.25) 
Tokyo grade II (moderate) 2.59 (1.51-4.43) 2.41 (1.21-4.80) 
Tokyo grade III (severe) 5.26 (0.72-38.58) 8.43 (0.97-72.9) 
CRP (per unit increase) 1.01 (1.00-1.01) 1.01 (1.00-1.01)
c
 
Acute cholecystitis in the medical history  2.12 (1.38-3.26) 3.63 (2.00-6.57) 
Acute pancreatitis  0.83 (0.24-2.92) 1.76 (0.41-7.52) 
Acute pancreatitis in the medical history 1.09 (0.61-1.96) 1.13 (0.50-2.59) 
Common bile duct stones 0.99 (0.59-1.66) 0.79 (0.39-1.61)
d
 
Intraoperative cholangiography 
  No intention 1.0 (ref)  1.0 (ref) 
Yes intention 0.68 (0.47-0.99) 0.48 (0.29-0.81) 
* matching variables 
  
a adjusted for age, gender, comorbidity, years with gallstone disease, laparoscopic or open cholecystectomy, Tokyo grade 
of acute cholecystitis, history of acute cholecystitis, acute pancreatitis, history of acute pancreatitis, and IOC. 
b Subgroup analysis, BMI was not used for confounder adjustment due to large number of missing values. 
c Subgroup analysis among patients with acute cholecystitis. CRP was not used in the multivariable models due to the large 
number of missing values. 
d Subgroup analysis, common bile duct stones was not used for confounder adjustment due to the missing data of 
operations without IOC. 
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6 DISCUSSION 
 
6.1 METHODOLOGICAL ASPECTS 
 
6.1.1 Paper I 
 
The population-based design with objectively collected administrative data on a vast 
majority of the cholecystectomies performed in Sweden during the study period and the 
essentially complete follow-up evaluation of cohort members is a major strength of this 
study. Even though the large sample-size to a large extent minimizes random errors and 
thus improves precision, some important remarks regarding the validity, i.e. potential 
systematic errors (bias), of the study need to be clarified. 
 
The population based design using the whole cohort of cholecystectomised patients 
minimizes the risk of selection bias and makes it well representative for the general 
population. However, some concern may be appropriate because several of the major 
university hospitals joined the Swedish Inpatient Registry rather late and BDI occurring 
at local hospitals but reconstructed at these referral hospitals were consequently not 
registered. This might reflect the rather low BDI incidence in the early part of the study 
period and possibly cause an overrepresentation of less severe BDI cases without the 
need of referral within the early years of the registry. This might partly explain the lack 
of improved survival, comparing different time periods, which would be anticipated 
given the improvement in handling surgical complications during the more recent time 
periods.  
 
Questions may also be raised regarding the identification of BDI and the risk of 
misclassification bias. Firstly, interpreting the results, it is important to keep in mind 
that identification of BDI through ICD-procedure codes for cholecystectomy with a 
subsequent biliary reconstruction only identifies a subgroup of patients with major BDI, 
as minor injuries usually can be handled by less invasive means[198-200]. The degree 
of misclassification of ICD-procedure codes have been shown to be as low as 2%, 
compared to the much more unreliable registration of diagnosis and complication 
codes[206].  Secondly, and of fundamental importance when it comes to survival 
analyses, it requires a complete identification of underlying malignant conditions in the 
hepato-biliary tract, not uncommonly associated with reconstructive biliary surgery and 
with the potential of severely influence the survival. Previous research, using this 
methodology for BDI identification within administrative data[120, 162, 183], claims 
to exclude possible malignancies although without stating if this identification was 
made on ICD-diagnosis codes. Russel et.al. used this methodology of BDI 
identification concluding only 47 of 175 possible BDI to be major injuries requiring 
reconstruction. The other 128 cases were minor BDI or malignant conditions not 
excluded by the used algorithm, the relative frequencies unfortunately not declared. As 
diagnostic ICD-codes have been shown[215] to be an unreliable source for malignancy 
identification, in paper I, the identification of these patients was based on linkage with 
the 98% complete Swedish National Cancer Registry[216] excluding subjects who 
previously, or within one year after the cholecystectomy had been diagnosed with a 
cancer in the upper gastrointestinal tract.  
   51 
In a study of this size, it was not possible to perform a manual review of the medical 
records and thus the risk of remaining misclassification bias cannot be completely 
disregarded.  
 
The survival analysis requires a complete follow-up and identification of censoring. 
The use of the individually unique national registration number permitted linkage of 
information across several registries. By linkage with the essentially complete Causes 
of Death Registry, we identified all death events among cohort members from the start 
of follow-up until death, emigration, or the end of the follow-up period (December 31, 
2005). Dates of emigration were obtained through record linkage to the National 
Registry of Emigration.  
 
One intention of the study was to evaluate if the incidence of cancer in the liver or bile 
ducts was increased after BDI. However, due to the relative rareness of these cancers, 
statistically well powered comparisons of the Standardized Incidence Ratio (the 
observed number of cancers divided by the expected number) was not possible.   
An important type of bias in epidemiological studies is confounding.  In the Cox model, 
we have controlled for the possible confounding effect of sex, gender, calendar period, 
comorbidity, method of reconstruction, reconstruction timing, IOC, hospital type and 
hospital caseload. However, there are possible confounders that we have not been able 
to control for. We have not been able to control for severity of the gallstone disease, the 
presence of inflammation or surgeon factors, all potentially influencing the survival. 
The severity of the gallstone disease and acute or chronic cholecystitis could not be 
determined with sufficient reliability and the identity of the surgeon is not among the 
registered variables within the Inpatient Registry. Moreover, the IOC registration is 
possibly biased by the inability to detect unsuccessful attempts for IOC not 
accompanied by an ICD code, with a subsequent overrepresentation of difficult cases in 
the non IOC-group. The reason for IOC usage could also not be clarified; IOC might be 
used to prevent BDI or to detect BDI, a matter of fundamental importance when 
interpreting the results.     
 
Finally, as the ICD code for laparoscopic cholecystectomy was introduced late in 
Sweden, and only gradually came to be used widely, it was not possible to distinguish 
reliably between laparoscopic and open cholecystectomies and consequently we did not 
stratify our risk factor analyses by open or laparoscopic procedure. 
 
 
6.1.2 Paper II 
 
The major strength of this study is the population-based design, with prospectively 
collected data from GallRiks, From the start of the registry in May 2005, a continuous 
validation process has disclosed a high validity of registered data. Annual reports deal 
with coverage and accuracy of registered data, and present web-based summaries that 
are easily available to participating hospitals and the community at large. 
 
Self-reported registries are always prone to a risk of selection bias, in which the 
reporting clinician might fail to report negative events related to the intervention, 
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thereby generating a falsely low rate of complications. To minimize losses in validity 
by data being self-reported in GallRiks, a local non-physician coordinator at each 
hospital reviewed complications and interventions 30 days after surgery. The review 
would look at pharmacological treatment, percutaneous drainage, endoscopic 
interventions, or reoperations. 
 
There might be some concern about how we used data at the start of the registry, even 
though the registry did not have nationwide coverage until 2009. However, the annual 
reports showed that data were valid, even for registration early in the period. Moreover, 
the risk of selection bias imposed by low coverage was largely relieved by the fact that 
coverage, even in the registry’s early years, was high at each participating hospital, and 
that the increased coverage during the period 2005-2009 has predominantly been by the 
addition of new hospitals and not by a gradual increase in coverage within each 
hospital. Since the Swedish healthcare system is largely based on hospitals with defined 
catchment areas, it is reasonable to consider the registry to be population based from 
the start of registration, since coverage has always been high within each catchment 
area. 
 
A study validating registrations of complications in GallRiks was presented in the 
registry’s annual report of 2010, comparing registration in the Swedish health insurance 
system with GallRiks data. All health related injuries associated with a 
cholecystectomy reported to the insurance system between 1 June 2005 and 31 May 
2010 were cross checked with GallRiks. All cases of BDI reported to the Swedish 
patient insurance were also documented as a BDI in GallRiks, indicating a good 
coverage of these cases in the registry throughout the study. Furthermore, 90% of 
cholecystectomies in the Swedish Inpatient Registry were also registered in GallRiks. 
Another strength of this study was the ability to detect the entire spectrum of injuries, 
ranging from less severe bile leakages after surgery (such as leakages from the cystic 
duct or lesions to peripheral ducts in the liver bed) to severe injuries (with transections 
with or without tissue loss located at or above the hepatic confluence). The vast 
majority of studies on this topic have focused either on major BDI, referred to and 
treated by tertiary hepato-biliary centres, or a selection of cases accessible to 
endoscopic treatment. Larger, population based studies originating from administrative 
national registries with injury identification through ICD diagnosis or procedure codes 
have substantial difficulties with the identification of less severe bile duct injuries, 
owing to the inconsequent registration of complication codes. A detailed registration of 
localization and extent of detected lesions in GallRiks enables a classification of 
injuries according to existing international classification systems. 
 
Unfortunately, data for concomitant vascular injuries were not registered in GallRiks, 
which could have understaged the severity of combined BDI and vascular injury, since 
the frequency of such injuries can be estimated to occur in approximately 25% of 
BDI[201]. 
 
There also might be arguments against including minor, postoperative bile leakages 
into the definition of BDI, since these are often managed conservatively, and only a 
minority of these leakages have been properly diagnosed and therefore eligible for bile 
duct injury classification. These injuries are rarely included in published incidence data 
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of BDI, although they are clearly defined as bile duct injuries in the majority of inter-
nationally accepted classification systems. Furthermore, even cystic duct leaks and 
small peripheral injuries cause bile leaks and have the potential of causing biliary 
peritonitis. It is thus highly relevant to include these minor BDI in research aiming at 
complication prevention.    
 
In the survival analysis using a Cox model, a few variables, listed in the method 
section, did not completely fulfil the proportional hazard assumption. To deal with this 
a stratified Cox models using a time varying covariate for the main exposure variables 
were used. Thus, the effect of these variables should be interpreted as the influence on 
survival during the first year after the cholecystectomy. In other words, the effect of 
these variables on survival varies over time. It is furthermore important to keep in mind 
that the follow-up is relative short and the excessive mortality seen within the study 
most likely represents post-operative complications rather than late complications due 
to stricture formation and recurrent episodes of cholangitis. 
 
The variables; emergency or planned admittance and the presence of acute cholecystitis 
or not were highly collinear. To handle this, only the variable representing the greatest 
confounding effect, emergency or planned admittance, was kept in the Cox model. 
 
A major advantage of the GallRiks registry is the IOC coding, identifying not only 
successful cholangiograms but also unsuccessful attempts. The inability to detect these 
failed attempts has been a major source of uncertainty within previous studies of the 
possible preventive effect of IOC. The reasons for the IOC are however still not known 
and this study setting cannot address the question regarding a safe surgeon effect.   
 
 
6.1.3 Paper III 
 
The methodological remarks of paper II, with regards to the validity and potential 
shortcomings of the GallRiks registry is comparable to this paper as the study base and 
BDI identification methodology are identical.    
 
There is no globally accepted gold standard classification of BDI. The Strasberg[97] 
classification is perhaps the most commonly used but lacks information about vascular 
injuries. The more recent, Hannover[99] classification is more detailed than the 
Strasberg classification, including vascular lesions and transferable. Concomitant 
vascular injuries are unfortunately not registered in GallRiks, potentially 
underestimating the severity of a BDI as the addition of a vascular component may 
influence and complicate even small ductal lesions. When sufficient information 
regarding injury extent and localization were available, we have classified injuries 
using the Hannover classification. For severity grading, injuries commonly requiring 
reconstructive surgery with cholangio-enteric anastomosis, i.e. transectional or 
obstructive lesions to the common bile duct or common hepatic duct as well as lesions 
above the hepatic confluence were considered to be severe. Consequently, lateral 
incomplete injuries, cystic duct lesions and peripheral minor leaks from the gallbladder 
bed were considered as non-severe. McMahon et. al[100] proposed a definition of 
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major and minor BDI where lacerations > 25% of the bile duct diameter, transections of 
the CBD or CHD or postoperative strictures were considered as major injuries. 
Lacerations < 25% of diameter or lacerations of the cystic duct-CBD junction were 
considered as minor. Our definition is similar to this with a few exceptions; We have 
chosen to consider lateral incomplete injuries below the hepatic confluence as non-
severe as these commonly are addressed without cholangio-enteric anastomosis. 
Furthermore, cystic duct leaks and peripheral leaks, not mentioned by McMahon are 
considered as less severe. Analyses addressing the severity using our definition or 
McMahon’s did not differ significantly (data not shown).    
 
The proportion of lesions without sufficient information for injury classification may 
seem high (191 of 747), but these are mainly postoperatively detected bile leaks 
discovered during the 30 day follow-up and the lack of injury classification is mainly 
due to limited clinical work-up rather than flawed registration.   
 
The GallRiks registry does not confirm the diagnosis of acute cholecystitis by 
histological report, and it is based upon clinical evidence and reported by the surgeon. 
This is a potential weakness as one might be concerned that the reporting of acute 
cholecystitis might be biased as surgeons causing an injury could be more likely to 
report generally difficult circumstances. However, analysing the subgroup of patients 
with BDI detected after the date of cholecystectomy, when the surgeon had already 
reported pre- and peroperative data without the knowledge of an injury, a similar risk 
effect of acute cholecystitis was seen (data not shown). 
 
One may argue that analyses of an association between IOC and BDI risk should not 
include minor injuries such as cystic duct leaks and peripheral ductal/Lushka leaks. 
However, possible associations between minor injuries and IOC include prevention of 
leaks from the cystic stump and minor peripheral lesions by the discovery, and 
subsequent handling of CBDS. The frequency of peroperatively detected CBDS among 
patients with a BDI was 18%. This rate is significantly higher than that of 12% in the 
whole cohort, a finding supported by previous research[199], strengthening the 
hypothesized causality between retained CBDS and minor injuries/leakages. Another 
reason for including cystic duct leaks/lesions in IOC research is that one of the 
arguments against the use has been that cystic duct cannulation may in fact cause 
injuries to the cystic duct with a subsequent higher risk of postoperative leakage[187]. 
 
As mentioned previously, one of the drawbacks of the GallRiks registry is that the 
reason for performing/not performing IOC cannot be clarified. We are unable to control 
for the safe-surgeon-factor. It is possible, and even likely, that a part of the protective 
effect of IOC is due to that some cholangiography-users are more likely to perform 
“safe surgery”. These surgeons might have reduced complication rates caused by a 
generally safe approach, rather than having a protective effect by the cholangiography 
per se. Flum et. al.[162] addressed the safe surgeon effect and concluded that surgeons 
performing IOC in more than 75% of their cholecystectomies had increased BDI rates 
when IOC was not used. However, this BDI and IOC data could not detect failed, BDI 
prone, attempts for IOC possibly explaining the whole difference.  
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6.1.4 Paper IV 
 
One of the strengths of this study is the population-based design. The study base, with 
all cholecystectomies performed in the area of eastern mid-part of Sweden 1990-2005, 
allows for identification of a relatively large number of cases despite the rareness of 
iatrogenic BDI. BDI identification through ICD procedure codes for surgical biliary 
reconstruction identifies only major injuries as minor injuries in particular may 
successfully be addressed by other means, such as interventional endoscopy. Those 
injuries will not be detected using this method, thereby restricting external validity, i.e. 
generalizability, to major biliary lesions.   
 
A case–control study offers advantages in research concerning rare outcomes, such as 
iatrogenic BDI. When detailed information regarding the surgical procedure or patient 
characteristics are lacking in registries, a case-control study with review of medical 
records is often the only cost-effective solution. On the other hand, the process of 
reviewing medical records may introduce information bias due to incomplete medical 
records which is a weakness in this study design.  
 
As falsely identified BDI cases and incomplete records were excluded, a conditional 
logistic regression with pair matched cases and controls would result in significant loss 
of power due to the exclusion of incomplete pairs. The solution of this problem was to 
break the match and subsequently analyse the data as frequency matched, controlling 
for the matched variables in unconditional logistic regression models. The loss of 
precision, using unconditional regression instead of conditional logistic regression was 
well compensated by the gained power of including all BDI cases. 
 
The review of the medical records enabled a detailed severity grading of patients with 
acute cholecystitis. The severity grading according to Tokyo Guidelines have the 
advantage of being easily determined in the clinical setting. It is furthermore globally 
accepted and offers favourable conditions regarding comparability of research.     
 
Regarding variable selection, the appearance of the gallbladder was not used for 
confounder adjustment, although generally available in the surgeon’s report. 
Undoubtedly interesting, this finding is however possibly strongly biased by the fact 
that surgeons causing BDI are likely to emphasize difficult circumstances like chronic 
cholecystitis in the postoperative report. The frequency of pathology reports was 
unfortunately too low for analyses with acceptable precision making the duration of 
gallstone disease the most reliable proxy for the impact of chronic cholecystitis.   
 
With this study setting, we were able to get detailed information regarding the use of 
IOC. We have continued to use the intention-to-do approach, adding failed attempts of 
IOC to the intended group. Moreover, some surgeons only used IOC to confirm and 
evaluate the extent of a suspected iatrogenic BDI causing an apparent high incidence of 
injuries in the cholangiography group. A thorough review of the surgical reports made 
it possible to identify operations where the cholangiography was used solitarily for BDI 
confirmation, after division and clipping of a suspected cystic duct, subsequently falling 
into the no-intention group. 
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6.2 FINDINGS AND IMPLICATIONS 
 
 
6.2.1 Incidence of bile duct injury 
 
Analysing data from the Swedish Registry for Gallstone Surgery, GallRiks (study I and 
II), we found a BDI incidence of 1.46%, with the majority (77%) being detected 
postoperatively. This exceeds by far the previously reported incidence figures 
averaging 0.25% in the era of open cholecystectomy and 0.55% after the introduction 
of the laparoscopic technique. The explanation for this is GallRiks ability to identify the 
whole spectrum of injuries, ranging from cystic duct leaks and minor peripheral ductal 
leaks to major injuries with complete transection of major ducts with tissue loss. If we 
restrict to major injuries requiring repair by cholangio-enteric anastomosis, the 
incidence drops to 0.11%, well comparable to the lowest incidence figures based on 
ICD-procedure codes of biliary reconstruction. It is thus obvious that the majority of 
BDI comprises minor and moderate BDI, not accurately measurable with the ICD-code 
methodology. As stricture development may take time, and GallRiks follow-up is 
limited to 30 days postoperatively, it is likely that the true incidence of BDI is even 
larger than presented here. Nevertheless, this incidence figure is probably among the 
most accurate estimate of BDI after cholecystectomy emphasizing the need of 
prevention and early diagnostic efforts when patients do not follow the expected 
recovery.             
 
 
6.2.2 Health consequences of bile duct injury 
 
The results of study I and II confirms the impaired survival after BDI reported by 
previous authors. In study I, surgically reconstructed BDI had a one-year survival of 
9.8%, corresponding to an adjusted HR for death 3.7 times that of non-injured. In study 
II, analysing survival in the GallRiks registry, with shorter follow-up period, one-year 
mortality after BDI (minor and major) was 3.9% with a HR for death 1.9 times that of 
non-injured. The excessive mortality in study II was almost confined to patients with a 
delayed discovery of the BDI due to postoperative bile leakage. The mortality figures 
reflect the detrimental impact of BDI but are considerably lower than those presented 
by Flum et. al.[2], who reported a one-year mortality of 26% after BDI in his Medicare 
cohort, using identical methodology to study I. However, the one-year mortality of non-
injured Medicare patients was as high as 6.6% reflecting the selection of an elderly 
population with significant comorbidity and severe socioeconomic situation, hardly 
comparable to the Swedish population of study I and II. In contrast to these results, 
DeReuver et. al.[140] reported a 10-year survival rate after BDI comparable to the 
general Dutch population, analysing 500 BDI patients treated at a tertiary referral centre 
in Amsterdam. Although a selected group, the striking survival differences compared to 
the results of Flum’s and the present studies, reflects the positive impact of proper 
multidisciplinary management by highly dedicated experts. It furthermore highlights 
the need of gaining acceptance for an early referral regime among the surgical 
community, used to taking care of their own complications. 
Study I further contributes to the knowledge of morbidity associated with BDI as the 
long follow-up allows for analyses of late complications. Patients requiring surgical 
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repair after BDI had a more than 4 times elevated Standardized Mortality Ratio of death 
due to liver related diseases, mainly cholangitis. Although not fully understood, a 
damage to the delicate vascularization of the biliary tree, often difficult to detect during 
the initial cholecystectomy, may be part of the explanation of late stricture 
development. A causal chain from stricture development, due to non-optimal healing 
after BDI repair, to biliary stasis and recurrent cholangitis points out the necessity of 
giving BDI patients the best available treatment. The 500 Dutch BDI patients in 
DeReuver’s[140] study were as previously mentioned at no excessive risk of death 
compared to the general population, but in 10 out of 42 deaths in the BDI group during 
follow-up, death was believed to be related to the biliary injury. Knowledge about 
morbidity and late complications emphasizes the importance of doing the right thing 
from start, choosing the optimal reconstruction strategy with the best timing, and 
having a thorough short- and long term follow-up regime in the handling of BDI.        
 
 
6.2.3 Prevention of bile duct injury 
 
Study III, IV and parts of study II are dedicated to the prevention of BDI, addressing 
important hypothesized risk factors and the widely debated use of IOC. Study II and III 
are based on the valid, Swedish Registry for Gallstone Surgery, GallRiks which offers 
unique conditions for high evidence research. Study IV aims for a complementary 
investigation of the importance of acute cholecystitis, not available for detailed 
evaluation in the GallRiks registry.     
 
6.2.3.1 Risk factors 
 
6.2.3.1.1 Age 
Patients’ age was an independent and significant risk factor for BDI in the risk factor 
analyses of study III. Age was furthermore a risk factor for death after sustaining a BDI 
(Study I and II). The findings are in line with result from previous research[118, 120, 
122]. Although there are many risks in performing surgery in elderly, many patients do 
well and benefits from the surgical procedure. Age alone should never be used as a 
criterion to deny patients otherwise indicated surgery.    
 
 
6.2.3.1.2 Gender 
In none of the studies of risk factors for BDI or risk factors for mortality after BDI did 
gender matter significantly. This might seem surprising as male gender has been 
associated with both excessive BDI rates and impaired survival in the few larger 
population based studies published[118, 122, 153]. However, these studies suffer from 
potential remaining confounding, better dealt with using information-dens registries as 
GallRiks. This statement may be supported by the consequent pattern of male gender 
being a risk factor in the crude analyses, but not after multivariable adjustment. The 
most important confounder being acute cholecystits, twice as common as indication for 
surgery among men compared to women.  
 
 
 58 
6.2.3.1.3 Comorbidity 
The burden of comorbidity, quantified by the validated[217] Charlson comorbidity 
index in study I and IV and by ASA-grade in study II and III, was an independent risk 
factor for BDI and impaired survival in all studies. These findings are in line with 
previous research, probably reflecting patients with a higher rate of previous surgery 
and more adhesions as well as the influence of non-surgical factors on wound-healing 
and recovery. It might furthermore represent residual confounding of a more advanced 
gallbladder disease and consequently more difficult procedures. 
 
6.2.3.1.4 Acute cholecystitis 
A main finding of paper III and IV is the impact of acute cholecystitis on the risk of 
BDI. Acute cholecystitis is a relatively common complication to gallstone disease with 
laparoscopic cholecystectomy as the treatment of choice. Previous population-based 
studies have not been able to show the association between increased BDI-rates and 
acute cholecystitis, mainly due to methodological limitations. The significant findings 
of Study III confirm, on a population-based level, that the presences of inflammation of 
the gallbladder or a history of inflammation are important risk factors for BDI. 
Furthermore, patients with acute cholecystitis benefits from early cholecystectomy, as 
soon as possible after emergency admittance. 
 
The suggested safety of laparoscopic cholecystectomy in patients with acute 
cholecystitis is based on high level evidence from randomized controlled trials. 
However, patients with acute cholecystits are a very heterogeneous group and in severe 
forms, often in combination with advanced age and comorbidity, cholecystectomy may 
result in serious morbidity and mortality[93-95, 218-220]. These patients are rarely 
included in randomized trials and the recommendations cannot be generalized to this 
patient group. In study IV, patients with acute cholecystitis were stratified according to 
severity and the findings are important. Patients with mild (Tokyo grade I) acute 
cholecystitis are at no excessive risk for sustaining BDI at cholecystectomy whereas 
moderate (Tokyo grade II) and severe (Tokyo grade III) forms have a gradually 
increasing injury risk. These findings imply the need of more research aimed for safe 
alternative treatments of acute cholecystitis and high risk patients.       
 
6.2.3.1.5 Other risk factors 
In the risk factor studies (study III, and IV) we investigated, but did not find any 
influence on BDI risk by patients BMI or the annual cholecystectomy caseload of 
surgeons and hospitals.  
The analyses suggested an increased risk by open cholecystectomy compared to 
laparoscopic approach, a finding most likely the result of residual confounding by a 
selection of suspected difficult cases to the open technique.  
 
CBDS were found at a higher rate among BDI compared to non-injured 
cholecystectomised patients. It suggests that CBDS might cause postoperative bile 
leakages by increasing the intraductal pressure, causing cystic stump blow-outs and 
persisting leaks from minor BDI. The results are however suffering from selection bias, 
as only patients with a successful IOC have the possibility of CBDS detection. 
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6.2.3.2 Intraoperative cholangiography 
 
The controversies regarding a possible protective effect of IOC against BDI have been 
an on-going matter of debate since even before the introduction of laparoscopic 
cholecystectomy. As high level evidence from randomized controlled trials is virtually 
impossible due to the rareness of BDI, single or multicentre case series, questionnaire 
based research, and observational population based research have, without success, 
tried to convince the surgical community of either the pros or cons of IOC.  
All of the four studies within this thesis are to some extent investigating the relationship 
between IOC and BDI. In study I, evaluating 374 042 cholecystectomies from 1965 to 
2005, the use of IOC significantly reduced the risk of death in patients with 
reconstructed BDI by 27%. The widely used methodology based on ICD-codes can 
however be questioned and the results are somewhat ambiguous. Study II, using the 
prospectively collected and valid GallRiks registry, poses major advantages regarding 
injury and IOC identification and represents the best level of evidence available on this 
topic. We introduced the intention-to-do IOC, including failed cholangiography 
attempts. IOC intention significantly reduced BDI rates by 29%, facilitating early 
injury detection. Moreover, the intentional use of IOC reduced the risk of death after 
cholecystectomy by 62%.  
 
Among the drawbacks of IOC, the prolonged operation time, added costs and risk of 
misinterpretation have made the selective approach dominating using IOC only in high 
risk patients. Available research have, up-to-date, not been able to show the safeness of 
this approach and the definition of high risk patients have not been clarified. In study 
III, we stratified the effect of intentional IOC on patients with acute cholecystitis, with a 
history of acute cholecystitis and with uncomplicated gallstone disease. It became 
evident that the protective effect of IOC on BDI risk was confined to patients with 
acute cholecystitis and patients with a history of acute cholecystitis. Patients with 
uncomplicated gallstone disease did not significantly benefit from IOC.    
The results from these studies, based upon best available data, suggest that the intention 
of IOC reduces BDI rates and improves outcome and survival after cholecystectomy. 
Evidence based recommendations of a selective approach can only be made among 
patients with uncomplicated gallstone disease whereas in patients with gallstone 
complications, such as acute cholecystitis, IOC should be routinely performed.                   
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7 CONCLUSIONS 
 
This thesis provides results to support the following conclusions: 
 
 The incidence of iatrogenic BDI in Sweden is approximately 1.5%, including 
minor and major injuries. 
 
 Iatrogenic BDI during cholecystectomy is associated with reduced short and 
long-term survival. 
 
 Patients with reconstructed BDI are at increased risk of dying from liver related 
diseases, especially cholangitis. 
 
 Increasing age and comorbidity are risk factors for BDI, and affects survival 
negatively following a BDI.  
 
 Patients with moderate (Tokyo grade II) or severe (Tokyo grade III) forms of 
acute cholecystitis or patients with a history of acute cholecystitis are at 
increased risk of iatrogenic BDI during cholecystectomy. On the other hand, 
patients with mild acute cholecystitis (Tokyo grade I) do not have an increased 
injury risk compared to patients without inflammatory changes of the 
gallbladder. 
 
 Postoperative, as opposed to peroperative, detection of BDI increases the risk of 
dying after a cholecystectomy. 
 
 IOC reduces iatrogenic BDI rates at cholecystectomy and improves survival 
after cholecystectomy. 
 
 The protective effect of IOC is confined to patients with acute cholecystitis or 
patients with a history of acute cholecystitis. Patients with uncomplicated 
gallstone disease does not significantly benefit from IOC.  
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8 POPULÄRVETENSKAPLIG SAMMANFATTNING 
 
Gallstenar har plågat mänskligheten genom historien, där den tidigaste påträffade 
gallstenen återfanns i den mumifierade kroppen av en Egyptisk prästinna från Amen 
(1085-945 f.Kr). Idag får gallstenssjukdomen betraktas som en folksjukdom, där ca var 
fjärde person i Sverige någon gång kommer utveckla gallsten, kvinnor i ca dubbelt så 
stor utsträckning som män. Även om endast en minoritet får symtom eller 
komplikationer av sina gallstenar kommer mellan 10 och 40 % att genomgå en 
operation någon gång i livet. Detta gör att en gallstensoperation, eller kolecystectomi, 
är den näst vanligaste operationen i Sverige med ca 11500 ingrepp varje år. En 
kolecystektomi är idag ett rutiningrepp, vanligen utfört med titthålskirurg, där patienten 
ofta går hem samma dag och återgår i arbete endast efter några dagars sjukskrivning. 
Allvarliga komplikationer är ovanliga men kan ge förödande konsekvenser.    
 
Denna avhandling fokuserar på den kanske mest förödande komplikationen under en 
kolecystektomi, en oavsiktlig skada på gallgångarna mellan levern och 
tolvfingertarmen. 
Lyckligtvis är skador relativt ovanliga och 
har rapporterats hos ca 0.5% av alla 
kolecystektomier. En allvarlig skada är 
potentiellt livshotande, innebär en lång 
sjukhusvistelse, ofta med behovet av flera 
kirurgiska ingrepp för att rekonstruera 
gallträdet, och samhällskostnaderna kan bli 
mycket stora. 
Den överlägset bästa metoden att behandla 
gallgångskador är att förebygga dem, och för 
det krävs en djup förståelse avseende 
uppkomst, konsekvenser, riskfaktorer och 
kirurgisk teknik. Tidigare forskningsinsatser 
inom detta område har haft svårigheter att 
kunna presentera tillförlitliga resultat som är 
säkra nog att bygga rekommendationer och 
behandlingsriktlinjer utifrån. I synnerhet 
har användande av gallvägsröntgen, s.k. 
intraoperativ kolangiografi, varit 
synnerligen omdebatterat. Förespråkare 
hävdar att denna röntgen minskar risken för skador medan motståndarna lyfter fram en 
förlängd operationstid, ökade kostnader och tveksam effekt.    
Genom fyra delarbeten har det i denna avhandling undersökts hur vanligt 
gallgångskador är, vilka konsekvenser det får för patienten avseende sjuklighet och 
överlevnad, vilka riskfaktorer det finns samt hur effektivt skador kan förebyggas med 
optimalt använda kirurgiska metoder.  
 
I det första delarbetet användes slutenvårdsregistret där data från alla behandlingar på 
svenska sjukhus registrerats från 1965. Data från åren 1965-2005 analyserades. 374 042 
Levern 
Djupa 
gallgången 
Gallblåsan 
Tolvfingertarmen 
Figur10. Gallblåsan och gallvägarna. 
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kolecystektomier och 1386 gallgångskador som genomgått kirurgisk rekonstruktion 
återfanns. Överlevnaden hos denna grupp var betydligt sämre än hos patienter utan 
skador och ca 10% dog inom det första året. Leverrelaterade sjukdomar var 
överrepresenterade som dödsorsak i denna grupp vilket talar för att skadan medför 
svårigheter för gallan att flöda fritt ut till tarmen med stas upp i levern som följd.     
  
I det andra delarbetet användes det svenska kvalitetregistret för gallstenskirurgi, 
GallRiks, som startades på uppdrag av Svensk Kirurgisk Förening 2005. Registret har 
snabbt kommit att bli ett av världens mest kompletta register över 
gallstensbehandlingar och täcker idag mer än 90% av alla kolecystektomier i Sverige. 
Genom att analysera 51 041 kolecystectomier mellan 2005 och 2010 fann vi 747 
(1.46%) gallgångskador, från små skador med endast läckage av galla till skador där 
stora delar av gallträdet oavsiktligt opererats bort. Överlevnaden efter en gallgångskada 
var bättre om skadan upptäcktes i samband med den ursprungliga operationen istället 
för efteråt. Ett viktigt fynd var även att gallgångsröntgen visade sig förbättra 
överlevnaden efter kolecystektomi, troligen p.g.a. att skador upptäcks i ett tidigt skede 
och begränsas i sin omfattning. 
 
I det tredje delarbetet fortsatte analyserna av materialet från GallRiks med speciellt 
intresse på riskfaktorer för gallgångskada och effekten av gallvägsröntgen. Resultaten 
visade att hög ålder, övrig sjuklighet och en pågående inflammation i gallblåsan vilket 
är en relativt vanlig orsak till operation, ökar risken för gallgångskada. Även patienter 
med en tidigare akut inflammation i gallblåsan, men ingen pågående vid 
operationstillfället, har en ökad skaderisk. Ett mycket viktigt fynd var att den 
skyddande effekten av gallvägsröntgen var som mest uttalad hos patienter med just 
pågående inflammation i gallblåsan. Skaderisken halveras hos denna grupp om röntgen 
används. Patienter med okomplicerade gallstensbesvär, utan inflammation har däremot 
ingen skyddande effekt av röntgen.  
 
I det fjärde och sista delarbetet fördjupades studierna av akut inflammation i gallblåsan 
och dess inverkan på skaderisk. Genom en s.k. fall-kontrollstudie, med 
journalgenomgång av 158 gallgångskador och 623 oskadade gallstensopererade 
kontrollpatienter, undersöktes om patienter med olika grader av inflammation har olika 
risk att drabbas av gallgångskada. Resultaten visar att patienter med mild inflammation 
inte har någon ökad risk medan patienter med måttlig eller svår inflammation har en 
gradvis ökad risk. Detta talar för att man kan behöva anpassa behandlingen och kanske 
till och med undvika operation när inflammationen är riktigt uttalad. 
 
Sammanfattningsvis har denna avhandling kunnat visa att gallgångskada vid 
kolecystektomi är vanligare än man tidigare trott, med försämrad överlevnad som följd. 
Detta beror sannolikt på en ökad dödlighet i leverrelaterad sjukdom orsakad av 
gallgångskadan. Hög ålder, samtidiga sjukdomar och inflammatoriska förändringar i 
gallblåsan är viktiga riskfaktorer för gallgångskada. Rätt användande av 
gallvägsröntgen minskar skaderisken och förbättrar överlevnaden efter kolecystektomi. 
Då den skyddande effekten av gallvägsröntgen kan visas hos patienter med 
inflammatoriska förändringar i gallblåsan bör detta utföras rutinmässigt hos denna 
patientkategori. Hos patienter med okomplicerade gallstensbesvär kan ett selektivt 
användande vara lika säkert.                             
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